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ABSTRACT 
Qunying Zhang 
Loyola University Chicago 
DEVELOPMENT AND FUNCTIONAL PROPERTIES OF 
INTRAMOLECULAR CROSSLINKED HEMOGLOBIN 
Doubly crosslinked hemoglobin, e,a-XLHbA, was made by reacting 
hemoglobin with bis(3,5-dibromosalicyl) fumarate under both oxy and deoxy conditions. 
The SDS~PAGE results indicated that there was over 95 % of inter-chain crosslinked. 
The thermal stability of this doubly crosslinked hemoglobin is 19.8 "C higher than 
uncrosslinked hemoglobin, and 4 °C higher than either of the single crosslinked species. 
It also has a low oxygen affinity and high cooperativity which are similar to that of 
a99XLHbA. The autoxidation rate is slower than that of a99XLHbA but close to that 
of uncrosslinked hemoglobin and e82XLHbA. This suggests that the double crosslinked 
hemoglobin, e,a-XLHbA, has the combined advantages over the singly crosslinked 
hemoglobins, a99XLHbA and e82XLHbA, higher stability, lower oxygen affinity and 
slower autoxidation rate. 
Bis(3,5-dibromosalicyl) sebacate is a long crosslinking reagent with 10 carbons 
between the two reactive groups. It reacts with oxyhemoglobin to produce a crosslinked 
hemoglobin between two e chains in the 2,3-bisphosphoglycerate binding cleft. The 
oxygen binding curve of this crosslinked hemoglobin had a P.50 value of 18.5 mmHg 
compared to the P 50 value of 11 mmHg for native hemoglobin and still remains highly 
cooperative. This suggests that the allosteric equilibrium of the crosslinked hemoglobin 
is effectively shifted to the T-like structure by introducing the crosslinker. Crosslinking 
hemoglobin between the two /3 chains also results in a 12.5 °C increase in the thermal 
denaturation stability. However the crosslinked hemoglobin is oxidized more rapidly to 
the methemoglobin form than Hb A was. 
l,5-Difluoro-2,4-dinitrobenzene (DFDNB) is a very short and neutral 
crosslinker. It crosslinks hemoglobin both between the two 0t. chains and between the two 
13 chains. The thermal stabilities of DFDNB-crosslinked hemoglobin are very high, even 
higher than those found for most doubly crosslinked hemoglobins. However, they have 
high oxygen affinity and low cooperativity, and very difficult to purify. 
CHAYfER I 
INTRODUCTION 
Blood Transfusion and Blood Substitutes 
The histories of blood transfusion and blood substitutes are complementary: 
without a need for transfusions, there would be no need for alternatives. The search for 
a blood substitute has paralleled the search for safe blood transfusion. Blood transfusion 
is a large business. More than 13 million units are collected each year. in the United 
States alone, and about 10 million units are transfused into 4 million recipients. Of these 
units, about two-thirds are used during surgery, and the rest are used for either medical 
or trauma indications (1). Continued development of invasive, aggres.sive medical and 
surgical procedures will also increase the demands placed on tlle blood supply. For 
example, each liver transplantation procedure requires about 100 units of blood (2). 
Furthermore, the increasing mean age of the population will demand more blood and 
blood products, since the requirement increases with age. 
Although donor blood is a good material for use in transflls.ions., there are a 
number of potential problems. First, blood cells have a limited storage time with 
standard storage procedures. Second, it requires careful typing and cross matching. 
About thirty-five transfusion-related deaths are reported to the Food and Drug 
Administration (FDA) each year, most of which are attributed to c1erical errors (ABO 
incompatibility) and bacterial infections. Third, donor blood has to depend on the 
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availability of donors. In major disasters or in war, enough donor blood may not be 
available, and there may not be time or facilities for typing and cross matching. Since 
it was found that the acquired immune deficiency syndrome (AIDS) could be transfused 
by a blood-borne virus (HIV) in 1983, the supply of blood for transfusion in the US has 
been diminishing. This arises from a combination of more efficient usage of banked 
blood and the unwarranted fear of many potential donors that the act of donation might 
expose them to viral infection (3). Fourth, there are also special cases related to rare 
blood groups, religion and special forms of surgery. Fifth, efforts to control the human 
HIV have drawn attention to other pathogenic viruses that can be potentially contained 
in blood. Finally, the AIDS epidemic has made both physicians and patients aware that 
there is an inherent risk in receiving banked blood. Therefore, there is an urgent need 
for extensive research efforts in red blood cell substitutes. 
Blood substitutes have been sought since the concept of the circulation of the 
blood was first discovered in the seventeenth century. Since then many materials have 
been tried as red cell substitutes, such as milk, normal saline, Ringer's lactate, gum-
saline, blood plasma and serum, albumin, perfluorochemicals and celJ-free hemoglobin. 
Among all these potential blood substitutes, perfluorochemicals and hemoglobin are the 
most interested. Perfluorochemicals are not antigenic. The emulsion of 
perfluorochemicals can dissolve oxygen up to 70 % per unit volume (4,5), their sizes 
are very small compared to that of RBC 's, and they could pass through occluded blood 
vessels. Unfortunately, perfluorochemicals accumulate in the liver and in the spleen to 
the point that these organs are unable to clear other foreign substitutes when they are 
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given to patients (6). Thus hemoglobin became the most interesting substance. 
Structure and Function of Hemoglobin 
The concept of using hemoglobin in solution as a blood substitute has been 
around for a long time because of its unique structure and function. Hemoglobin is 
probably the most studied and best understood human protein. Hemoglobin is the oxygen 
carrying protein in the erythrocyte. 1 ml of blood has approximately 5 billion 
erythrocytes and each erythrocyte is packed with 280 million molecules of hemoglobin. 
The role of hemoglobin is to bind molecular oxygen to its heme irons in the lungs, 
deliver it to the various tissues throughout the body, and transport carbon dioxide from 
the tissues back to the lungs to get rid of it. Hemoglobin A was one of the first proteins 
whose primary structure was determined. About two-thirds of the residues of each chain 
are arranged in seven and eight helices of the a and (3 chains, respectively. The helices 
are designated from A to H and vary from seven to twenty residues in length. Human 
hemoglobin consists of four polypeptide chains: two identical a chains, with 141 amino 
acids and a molecular weight of 15, 126 daltons, and two identical (3 chains, with 146 
amino acid residues and a molecular weight of 15,867 each. The heme adds another 
616 daltons to each chain. Therefore, a hemoglobin tetramer has a molecular weight of 
64,450 daltons (5). 
A very important factor stabilizing the globin chain structure is the presence of 
the heme. Free globin is much less soluble than the molecule containing heme. Heme 
is embedded firmly into a "pocket" in each of the chains. The heme contains an iron (II) 
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ion at the center which plays an important role in ligand binding. The iron (II) ion is 
coordinated to the four nitrogen atoms of the pyrrole rings of the heme. The iron (II) 
can form additional bonds, one on either side of the heme plane. These two bond sites 
are termed the fifth and sixth coordination sites. The fifth coordination site is 
coordinated to histidine F8, which is called the proximal histidine, whereas the sixth 
coordination site is the binding site for the ligands. Although the distal histidine E7 is 
not linked covalently to the heme group, its presence in the heme pocket is important 
in maintaining spatial relationships. 
The function of hemoglobin in oxygen binding can best be understood on the 
basis of at least two separate quaternary conformations corresponding to the oxy and 
deoxy state. When oxygen is bound to hemoglobin, oxyhemoglobin is formed, and the 
quaternary conformation is described as a R state (R stands for relaxed) with high 
oxygen affinity. Another state in which the iron ion is still in the + 2 oxidation state, but 
with no oxygen bound to it, is called the T state (T stands for tense) with low oxygen 
affinity. The X-ray crystallographic studies demonstrated that the quaternary structure 
of oxy- and deoxyhemoglobin differ markedly (7-8). 
Oxygen can only bind to hemoglobin when the iron ion is the +2 oxidation 
state, ferrohemoglobin. When the iron ion is oxidized to the + 3 state, it can ligand to 
a H20 molecule, and it is called ferrihemoglobin or methemoglobin. 
Hemoglobin-Based Blood Substitutes 
The interest in hemoglobin as a blood substitute is based on several remarkable 
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characteristics of the hemoglobin molecule. First, hemoglobin has the capacity to bind 
oxygen. One gram of hemoglobin can chemically bind 1.3 ml of oxygen. Second, the 
hemoglobin molecule has the ability to become fully saturated with oxygen at ambient 
oxygen pressures. Thus, hemoglobin can be fully effective as an oxygen carrier without 
the addition of extra oxygen to the air. Third, oxygen is normally unloaded from 
hemoglobin in the capillaries at oxygen pressures of approximately 40 mmHg. This 
unloading characteristic allows for oxygen molecules to flow from hemoglobin to the 
intracellular mitochondria without producing interstitial hypoxia. Furthermore, a low 
viscosity hemoglobin solution might be able to perfuse tissue better than whole blood. 
It might be able to unload its oxygen in tissues more readily because it would not be 
required to diffuse through the red cell membrane and through the layer of unstirred 
plasma surrounding it. These beneficial effects could lead to a very efficient transport 
of oxygen especially in conditions of vascular obstruction or circulating collapse. 
However, researchers have known for decades that simply purifying hemoglobin from 
red blood cells and infusing it into the bloodstream does not work. After hemoglobin is 
removed from the red blood cells it acquires two shortcomings as a "blood substitute". 
First, it holds onto oxygen molecules much more tightly-so tightly that it will take 
oxygen from the lungs but release little of it into the body's tissues. Second, although 
the intact hemoglobin molecule is too big to be screened out of the blood by the kidneys, 
once hemoglobin is removed from the red blood cells it is quickly lost from the vascular 
system (vascular half-life -3 h). This short half-life is associated with the ability of 
hemoglobin tetramer to break down into two equally-sized dimers that are filtered out, 
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often causing major kidney damage. 
The two basic approaches to overcome these difficulties are: molecular 
modification and environmental modification. Molecular modification can be achieved 
in 3 ways, 1) intermolecular modification which crosslinks hemoglobin with 2 or more 
molecules, 2) intramolecular modification which crosslinks hemoglobin between two 
subunits and 3) hemoglobin-macromolecular modification which crosslinks hemoglobin 
to a non-extractable macromolecule, such as dextran. Environmental modification 
requires hemoglobin encapsulation to simulate erythrocytes. 
A number of molecular modifications has been proposed to improve the 
properties of hemoglobin as a blood substitute (Table 1). They include random 
nonspecific multisite crosslinking and site-specific crosslinking. There are two types of 
random nonspecific multisite modifications. One is by using bifunctional reagents, such 
as glutaraldehyde (9-14) and imidoesters (15) to crosslink hemoglobin, and the other one 
is to conjugate hemoglobin to a macromolecule, such as polyethylene glycol (16-17) or 
dextran (18-21) to increase the plasma retention time. Although some of these modified 
hemoglobin solutions have higher stability and lower oxygen affinity, they possess the 
obvious disadvantages that the products are heterogeneous or polydispersed. They are 
composed of macromolecules having different molecular weights and /or shapes. 
Molecular heterogeneity is a severe liability especially when the added products produce 
undesirable side effects. It is then very difficult to define the nature or the origin of the 
deleterious material. 
Most of the crosslinking reagents were made to react with amino groups of 
Class 
Lys 82(31 - Lys 82(32 
Lys 99a1 - Lys 99a2 
Val 1(31 - Lys 82(32 
Val 1(31 - Val 1(32 
Surface, multisite 
Conjugated hemoglobin 
Table 1 
Classes of Hemoglobin Modifications 
Example 
bis(3,5-dibromosalicyl) fumarate 
trimesoyl tris(3 ,5-dibromosalicylate) 
bis(3,5-dibromosalicyl) fumarate 
NFPLP 
bis-pyridoxal polyphosphate 
trimesoyl tris(methyl phosphate) 
DIDS 
Glutaraldehyde 
Imidoesters 
Polyethylene glycol 
Dextran 
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hemoglobin, but since each of the a{3 dimer of hemoglobin has 24 primary amino groups 
which can react, the functional group specificity is insufficient to give homogeneity. 
Thus reagents should be developed which have a added specificity for particular regions 
of the protein (7, 22-24). One of the most interesting small regions of the hemoglobin 
molecule is the (3 cleft or the 2,3-bisphosphoglycerate binding sites. X-ray diffraction 
studies by Arnone (25) indicate that 2,3-BPG binds electrostatically to the {3 chains of 
deoxyhemoglobin at a specific site in the entrance to the central cavity along the dyad 
axis. The phosphate groups of the 2,3-BPG salt form bonds with the (3 N-terminal amino 
groups and the imidazoles of (3 2 histidine and (3 143 histidine. The carboxyl group of 
the 2,3-BPG is bonded to the E-amino group of (3 82 lysine. Several specific crosslinkers 
have been found to react at this small region and some other specific amino acids. 
In 1975, Benesch et al. (26) used 2-nor-2-formylpyridoxal-5 '-phosphate 
(NFPLP) which, after reaction with deoxyhemoglobin and reduction with sodium 
borohydride, forms a covalent bridge between (31 Val 1 and {32 Lys 82. The negative 
charge from the phosphate group of the pyridoxal compound has an electrostatic 
interaction with the positive charges from the amino acid residues in the BPG cleft. This 
effect stabilized the T state which mimics closely the effect of BPG on hemoglobin (27-
29). However the synthesis of the NFPLP reagent is somewhat difficult and time 
consuming which probably explains why it has not become commercially available in the 
19 years since it was first studied (30-31). In 1988, Benesch and Kwong (32-33) also 
developed a new class of bis-pyridoxal polyphosphate compounds to crosslink 
deoxyhemoglobin between the amino terminus of a {3-chain and the lysine 82 of the other 
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(3 chain, as in the case for NFPLP. The yield of the crosslinked hemoglobin varied with 
different derivative compounds. These crosslinked hemoglobin derivatives have 
structures close to that of the deoxy state, with a low oxygen affinity while retaining 
cooperativity. 
Using dicarboxylic acid bis(methyl) phosphates to crosslink hemoglobin is 
another approach (34-36). These crosslinkers only react with the amino acids, Vall, 
Lys82 and Lys144 of the ,B-chain. No amino groups from the a-chain were acetylated 
in oxyhemoglobin. This result indicated that these reagents must be binding like the 
phosphate anion moiety in the BPG cleft before acetylation. All the modified 
hemoglobins exhibited low oxygen affinity and high Hill coefficients. 
Walder and his collaborators (37-38) showed that bis(3,5-dibromosalicyl) 
fumarate reacts with oxyhemoglobin to crosslink the (3 chains between {3 1 Lys 82 and (32 
Lys 82. However, the same compound, when applied to deoxyhemoglobin, leads to the 
formation of a bridge between Lys 99 and Lys 99 of the a chains (39). Kavanough et 
al. ( 40) isolated a hemoglobin A derivative crosslinked between the two /3 chain terminal 
Val residues from the mixture of products formed in the reaction with trans-4,4'-
diisothiocyanatostilbene-2,2 '-disultonic acid (DIDS). The crosslinked hemoglobin had 
lower oxygen affinity than that of whole blood ( 40). 
Kluger et al. (42) synthesized two three-point crosslinkers: trimesoyl tris(3,5-
dibromosalicylate) which reacted with deoxyhemoglobin and carbomonoxyhemoglobin 
to produce amides from the E-amino groups of Lys-82 of each of the {3 chains (41) and 
trimesoyl tris(methyl phosphate) which reacted selectively with the amino groups, (31 Val 
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and {382 Lys (42). 
The biologic and toxicologic effects of infusions of the crosslinked hemoglobin 
solutions have been studied by many researchers. The literature which has accumulated 
regarding the "toxic" effects of these crosslinked hemoglobins, is extensive and 
conflicting. There are still no products available for clinical use at this time. 
Development of Singly and Doubly Crosslinked Hemoglobins 
A suitable blood substitute needs to be free of infectious vectors, have a low 
toxicity, cause no reperfusion injury, provoke no immunological response, have an 
oxygen uptake similar to whole blood, possess a prolonged half-life in circulation and 
shelf-life, show slow autoxidation to methemoglobin, and be soluble in blood. Previous 
research indicated that hemoglobin could be protected from dimer dissociation by 
crosslinking the two identical chains (43). Single and double crosslinks between the 
subunits of hemoglobin may have the potential to satisfy this long list of requirements. 
Our research project is focused on developing new crosslinked hemoglobins and 
characterizing their structural and functional properties. The purpose of developing 
crosslinked hemoglobins is to use them as potential blood substitutes. All the 
crosslinking reagents used in this dissertation are either readily available commercially 
or are very easy to synthesize with high yields. They can provide a conveniently large 
quantity of product at low cost. 
Double Crosslinking Hemoglobin with Bis(3.5-Dibromosalicyl) Fumarate 
It has been observed that the anionic bifunctional reagent bis(3, 5-dibromosalicyl) 
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fumarate shows selectivity for certain amino groups of hemoglobin A. This reagent was 
found to crosslink oxyhemoglobin A between the Lys 82(31 and Lys 82(32 (37-38). The 
crystallographic investigation of the structure of (382XLHbA revealed that the overall 
structure was not changed. However, a local perturbation occurred around the crosslink 
in the BPG binding site. This perturbation caused the F helix, the EF comer, His 143 
and the amino termini of the (3 chains to move slightly toward the center of the cavity 
(37-38). These results have been substantiated by a recent high-resolution structure of 
(382XLHbA (44). The same reagent had the ability to selectively crosslink 
deoxyhemoglobin between Lys 99a1 and Lys 99a2 (39). 
The oxygen binding properties, thermal stability and autoxidation rate of (3 
crosslinked hemoglobin A ({382XLHbA) and a crosslinked hemoglobin A (a99XLHbA) 
were investigated (37,39,45-51). The oxygen affinity of (382XLHbA was higher than 
uncrosslinked hemoglobin A and was not affected by the presence of BPG or IHP. The 
oxygen affinity of a99XLHbA was, however, lower than that of hemoglobin A, and was 
greatly affected by presence of BPG. When BPG was present, the oxygen affinity of 
a99XLHbA was decreased to a value that was very close to that of whole blood. Despite 
the presence of the crosslink in hemoglobin, both a99XLHbA and J382XLHbA remained 
highly cooperative in terms of oxygen binding. But the autoxidation rate of a99XLHbA 
is faster than those observed with (382XLHbA and hemoglobin A. ~82XLHbA and 
hemoglobin A had essentially the same autoxidation rates. Both a99XLHbA and 
(382XLHbA had similar thermal stabilities with denaturation temperatures about 15 °C 
higher than that of hemoglobin A. 
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A suitable blood substitute should have both low oxygen affinity and a low 
autoxidation rate. Both o:99XLHbA and /382XLHbA could not satisfy these requirements. 
o:99XLHbA had a low oxygen affinity, but its autoxidation rate was high. On the other 
hand, the /382XLHbA had a low autoxidation rate but a high oxygen affinity. If a 
crosslinked hemoglobin had both advantages of o:99XLHbA and /382XLHbA, such as 
low oxygen affinity and low autoxidation rate, it could be proposed as being suitable to 
meet the basic requirements of a blood substitute. 
One approach is to double crosslink hemoglobin by using DBSF under two 
different conformational states. Double crosslinking hemoglobin means to crosslink 
hemoglobin twice at two different positions. DBSF has the ability to double crosslink 
hemoglobin at two different subunits, both between two a and two /3 chains. Figure 1 
shows the doubly crosslinking reaction of DBSF with hemoglobin under two different 
conditions. The double crosslinked hemoglobin could have low oxygen affinity and low 
autoxidation rate at the same time. The double crosslinking reactions could lock the 
quaternary structure of hemoglobin more tightly than for the singly crosslinked 
hemoglobins. Therefore doubly crosslinked hemoglobin would have a higher stability 
than either hemoglobin A or both singly crosslinked hemoglobins. 
Modification of Hemoglobin by 1.5-Difluoro-2.4-Dinitrobenzene 
1,5-difluoro-2,4-dinitrobenzene (DFDNB) is a bifunctional acylation reagent 
with a preference for amino and phenolic groups but also capable of reacting with 
sulfhydryl and imidazole groups (52). DFDNB has been used to study both 
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Fig. 1. Reaction of bis(3,5-dibromosalicyl) fumarate with hemoglobin 
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intermolecular (53) and intramolecular (54) crosslinking of proteins as well as a 
crosslinking reagent for phospholipids (55). The distance between the two fluorine atoms 
in DFDNB is approximately 4.8 A (56), which is a fairly short reagent compared with 
other crosslinkers. 
From previous work, we expected that a short reagent may lock the hemoglobin 
quaternary structure more tightly. Since the molecule may be more constrained, its 
stability may be higher. Thus, the DFDNB may crosslink hemoglobin and give greater 
stability than a longer crosslinker. 
Modification of Hemoglobin A with a Long Diaspirin Reagent 
A series of diaspirin compounds, such as bis(3,5-dibromosalicyl) fumarate, 
succinate, glutarate and adipate were synthesized by Klotz and co-workers (37-38) during 
1979 and 1980. These reagents were found to crosslink hemoglobin between subunits. 
One of example is DBSF as mentioned above. Molecular modeling studies provide us 
with a tool to measure the distance between the potential amino groups where the 
crosslinker may attack. Bis(3,5-dibromosalicyl) sebacate with a total of 10 carbon atoms 
between the two reactive groups is a long diaspirin reagent compared with other 
diaspirin reagents. From the size and the reactive groups present in this crosslink, we 
expected that this long diaspirin crosslinker would also react within the 2,3-BPG binding 
site. 
Reduction of MetHb A to OxyHb A 
Maintenance of hemoglobin A in the reduced (Fe +z) states is necessary not only 
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for the regular function of the red cell but also for investigators who are examining the 
functional properties of hemoglobin A, such as, oxygen affinity and autoxidation rate. 
The reduction of hemoglobin A in circulating red cells depends on a well-regulated 
system of electron carriers and enzymes. Methemoglobin A can also be reduced by other 
enzyme systems and chemical agents. 
Dithionite is the agent most often used in the laboratory to reduce metHb A. 
S 0 2- + 2HbFe3+ + 2H 0 -- > 2SO 2- + 2HbFe2+ + 4H+ 2 4 2 3 
In addition, dithionite can also reduce oxygen to peroxide: 
This undesirable side reaction can be minimized if dithionite is used under 
strictly anaerobic conditions. Furthermore, the time during which dithionite, its by-
products, and side products are in contact with hemoglobin A should be kept to a 
minimum. This can be achieved by procedures utilizing gel filtration. On a Sephadex 
G-25 column, the reduced hemoglobin A is separated effectively from the unwanted 
small charged molecules produced during heme reduction (57). 
Oxygen Binding of Hemoglobin 
For hemoglobin A to fulfill its physiological role, it must bind to oxygen with 
an appropriate affinity. If the hemoglobin-oxygen binding was too weak, blood would 
not become oxygenated in the pulmonary circulation; if it was too strong, insufficient 
oxygen would be unloaded to tissues. Oxygen binding is usually expressed by an oxygen 
dissociation curve which is the plot of hemoglobin saturation (Y) versus the partial 
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pressure of oxygen (pOJ. The saturation parameter Y is defined as the fractional 
occupancy of the oxygen binding sites. The value of Y can range from 0 (all sites 
empty) to 1 (all sites filled). The affinity of oxygen for hemoglobin A can be 
conveniently expressed by the term P 50, the oxygen tension at which hemoglobin A is 
half saturated. The higher the affinity of hemoglobin A for oxygen, the lower the P 50 and 
vice versa. Thus, P 50 is inversely related to oxygen affinity. 
Hemoglobin is an allosteric protein. The binding of four oxygen molecules to 
the four hemes of hemoglobin is not independent. Binding of oxygen to one heme 
facilitates binding of additional oxygen molecules to the other three hemes. This 
interactive binding phenomenon is termed cooperativity. The hemoglobin molecule also 
acts in a cooperative manner in releasing molecular oxygen. The sigmoidal shape of the 
hemoglobin oxygen binding curve indicated the presence of cooperativity. The Hill 
equation has proved very useful in expressing oxygen binding data. 
y p02 
log ( -------- ) 
1-Y 
= n log ( --------- ) 
P50 
If measurements of oxygen equilibria are plotted according to the Hill equation 
with log(Y I 1-Y) on the ordinate and log p02 on the abscissa, a linear plot would be 
expected. The x intercept of this line at Y = 0.5 gives the P50 value. The slope of this 
line, n, is a measure of subunit cooperativity. 
In the initial stages of oxygen binding (Y < 0.1) there is no subunit 
cooperativity, as documented by the fact that the slope of the Hill plot approaches 1.0. 
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It is likely that during this initial binding of ligand to the heme, the hemoglobin remains 
in the "deoxy" state. When all hemoglobin molecules are at least 75% saturated (Y > 
0.9), the slope of the Hill plot again approaches 1.0, and the hemoglobin again becomes 
noncooperative. All of the hemoglobin is now in the "oxy" state. 
Besides oxygen, there are many small molecules and ions with physiological 
relevance which can bind to hemoglobin, such as carbon dioxide, 2,3-
bisphosphoglycerate (BPG), chloride ion, and hydrogen ion (Fig. 2). These molecules 
and ions play very important roles in the oxygenation mechanism. 
In the physiological range, the oxygen affinity is decreased with the decreasing 
of pH. The oxygen affinity is also decreased with the increasing of the concentration of 
carbon dioxide. These linkages between the binding of oxygen, hydrogen ion and carbon 
dioxide are known as the Bohr effect. Because of the Bohr effect, carbon dioxide 
exchange facilitates oxygen exchange and vice versa. The binding of chloride ion to 
hemoglobin has been studied by many methods (58-62). In the absence of 2,3-BPG, 
two sites on deoxyhemoglobin appear to that have relatively high affinity for chloride 
ion: the amino group at the N terminus of the a chain and the amino group of (382 
lysine. The interaction of chloride ion at the N terminus of the a chain appear to be an 
important determinant of hemoglobin function. Chloride ion binding at this site stabilized 
the protonation of this amino group, thereby raising its pKa. Upon oxygenation, both 
the chloride ion and proton ions are released. Thus, part of the pH dependency of 
oxygenation (the Bohr effect) is linked to chloride ion binding. In fact, the Bohr effect 
decreased by about half when the chloride ion concentration was reduced from 
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physiologic (0.1 M) to zero (63). BPG also can decrease oxygen affinity by enhancing 
the stability of the deoxy conformation. Inositol heaxphosphate (IHP), like BPG, can 
decrease the oxygen affinity. 
As mentioned above, the oxygen affinity of the R state is similar to that of the 
free ex and (3 subunits or dimers composed of one ex and one (3 subunit, while the oxygen 
affinity of the T state is lower. Methemoglobin is not able to bind oxygen. Thus, the 
oxygen affinity of a hemoglobin solution is decreased in direct proportion to the amount 
of methemoglobin. The oxygen affinity of modified hemoglobin would depend on the 
size of the crosslinker, the sites of crosslinking, and the conformational state of the 
crosslinked hemoglobin. 
Thermal Stability of Hemoglobin 
Stability is an important functional property of any protein. One of the 
requirements of a suitable blood substitute is high thermal stability. The thermal stability 
of human hemoglobin is known to be fairly low, even under mild solution conditions 
(e.g. neutral pH, low salt concentration, etc). Exposure to temperatures above 50 °C 
causes rapid (within minutes) irreversible denaturation with precipitation (64). Since 
the isolated ex and (3 chains are even less stable than the hemoglobin tetramer, 
dissociation of the tetramer is often assumed to be a prerequisite for thermal unfolding, 
albeit in the absence of direct evidence. Thus, the crosslinked hemoglobin tetramer 
would be expected to have high thermal stability. 
The thermal stability of a protein can be measured by the melting temperature, 
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Fig. 2. Effect of ionic strength, pH, and 2,3-BPG on the oxygen affinity of 
hemoglobin 
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Curve c1- pH D?G 
(M) (mM) 
A O.D1 8.0 0 
s O.iO 8.0 0 
c O.i 0 5.4 0 
D O.iO 6.4 10 
5 10 50 
P02 (mm Hg) 
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the enthalpy, the entropy and the free energy of denaturation. The denaturation is the 
disorganization of the natural protein molecule, the change from the regular arrangement 
of structure to the irregular, diffuse arrangement of the flexible open chain without any 
alteration of the amino acid sequence. The thermal denaturation of protein may be 
reversible or irreversible depending on the protein under consideration and the conditions 
used. A reversible denaturation would be one in which the native structure is recovered 
by reversing the conditions after denaturation (65). The denaturation conditions which 
were used here lead to irreversible denaturation. The denatured state of hemoglobin is 
thought to be a highly disordered state in which the heme may or may not be intact in 
the globin chains (66). 
There are two common methods to determine the denaturation of hemoglobin: 
(1) by measuring the amount of precipitation of hemoglobin as a function of time at a 
particular temperature (67) or (2) the unfolding of hemoglobin is determined from the 
absorbance changes as a function of increasing temperature, which is the method we 
used in this dissertation ( 46-47). 
The thermal stability of several crosslinked hemoglobins have been distinguished 
and evaluated by this thermal denaturation technique (46-48,66-67). The thermal 
denaturation of hemoglobin can provide very important information, such as what 
crosslinking reagents can stabilize the hemoglobin structure the most, and to what 
temperature the crosslinked hemoglobin can be heated without causing denaturation. 
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Autoxidation of Hemoglobin 
A normal physiological function of hemoglobin is the reversible binding of 
dioxygen, which can only occur with the heme iron in the reduced state. In red blood 
cells, hemoglobin slowly oxidizes to methemoglobin at a rate of about 3 % per day. 
However the level of methemoglobin in the body remains constant at 1 % because 
whatever oxidized hemoglobin A (MetHb A) is formed in red cells, it is readily reduced 
back to ferrohemoglobin A by an enzyme system, methemoglobin reductase and NADH-
cytochrome b5 reductase (68-69). Outside the erythrocytes, the amount of methemoglobin 
can no longer be controlled at such low level because these enzymes are not present. 
The autoxidation may be lead hemichromes formation and protein denaturation, Heinz 
body formation and other changes (70-71). Heinz bodies interact with the cell 
membrane, alter cellular properties, and are found in the red cells of individuals with 
unstable hemoglobin and in senescent red blood cells (72). 
The autoxidation reaction of hemoglobin is a complex process. The autoxidation 
rate of hemoglobin is affected by many factors, such as pH, oxygen pressure, 
temperature and 2,3-BPG concentration. The autoxidation rate increased with increasing 
temperature, but decreased as the pH or oxygen pressure increased (73-74). However, 
the rate of autoxidation increased at either very low pH or at very high pH (74-75). 
The autoxidation of hemoglobin is enhanced by the dissociation of the dimer 
(76). The autoxidation studies of isolated a and {3 chains indicate that the a chain 
autoxidized faster than the {3 chain, and that the autoxidation rate also decreased with 
increased pH and oxygen pressure as did the hemoglobin tetramer (77-78). 
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In the presence of BPG or IHP, deoxyhemoglobin autoxidized faster than 
oxyhemoglobin (79-80). The individual subunits autoxidized faster when BPG or IHP 
were present than without these allosteric anions (79). The fact that the autoxidation 
reaction is favored by BPG or IHP suggested that the deoxyhemoglobin autoxidation is 
faster than that for oxyhemoglobin. 
The mechanism of the autoxidation reaction has been studied for a long time. 
The most probable scheme for the autoxidation reaction is presented in figure 3. 
25 
Fie. 3. Mechanism of the autoxidation reaction 
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CHAYfER II 
MATERIALS AND METHODS 
I. Materials 
DEAE-Sephadex A-50 gel, tris(hydroxymethyl)aminomethane, bromophenol 
blue, glycine, 4-morpholinepropane sulfonic acid, SDS protein markers, catalase, 
carboxymethyl cellulose (CM52) gel, antifoam A, ammonium sulfate, dalton mark VI 
SDS molecular weight standards, DPCC trypsin, trifluoroacetic acid (sequential grade) 
and inositol hexaphosphate were purchased from Sigma Chemical Company. Sodium 
dodecyl sulfate, 1,5-difluoro-2,4-dinitrobenzene, sulfo-SANPAH, amino acid standards, 
phenylisothiocyanate, 0.2 micron filters (nylon-66) and guanidine hydrochloride were 
obtained from Pierce Chemical Co. 3,5-dibromosalicylic acid, fumaryl chloride, sebacoyl 
chloride, dimethylaniline, urea, 2-mercaptoethanol, (methyl sulfoxide)-d6 , N,N-
dimethylaniline, silica TLC plates, benzene and barium chloride were obtained from 
Aldrich Chemical Co. Hydrochloride acid, glacial acetic acid, sodium hydrosulfite, 
methanol, ammonium bicarbonate, acetonitrile, acetone, ethanol, ethyl ether, chloroform, 
sodium phosphate dibasic, sodium phosphate monobasic, disodium ethylenediamine-
tetraacetate, glycerol, dialysis tubing, micro-ProDicon membrane, pH standard buffers 
and triethylamine were purchased from Fisher Scientific Co. Sephadex G-25, G-100, 
Sephacryl S-200, PhastGel Homogenous 7.5, PhastGel sample applicator 8/1, PhastGel 
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SDS buffer strips and PhastGel Blue R were from Pharmacia Chemicals. Sodium 
cyanide, boric acid and sodium hydroxide were purchased from J. T. Baker Chemical 
Co. Sodium chloride, sodium acetate, potassium ferricyanide and potassium chloride 
were obtained from Mallinckrodt, Inc. 0.2 Micron Membrane filters was from Gelman 
Sciences. Centrcon tube and PM-10 membrane were purchased from Amicon. Alkaline 
agarose gel, amido black and sodium barbital buffer were purchased from Corning 
Medical. 
II. Synthesis 
Synthesis of Bis(3,5-dibromosalicyl) Fumarate 
The synthesis of bis(3 ,5-dibromosalicyl) fumarate was done according to the 
method of Zaugg et al. (23). 3,5-dibromosalicylic acid (3.776 g, 12.8 mmol) and N,N-
dimethyl aniline (3.213 ml, 25.3 mmol) were added in dry benzene (50 ml). The 
solution was stirred slowly to allow homogeneity for a few minutes at room temperature. 
To this solution fumaryl chloride (0.675 ml, 6.24 mmol) was added slowly with stirring. 
After 3 hours of stirring at room temperature, water (15 ml) was added, and the solution 
was acidified with 12 M HCl (1 or 2 drops). A large amount of precipitate was observed 
after another 20 minutes of stirring. The precipitate was washed with benzene (2 x 50 
ml) and recrystallized from a 50 : 50 hot acetone-water mixture twice. 
Synthesis of Bis(3,5-Dibromosalicyl) Sebacate 
Bis(3,5-dibromosalicyl) sebacate was synthesized following a modified method 
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of Zaugg et al. (81). Two equivalents of 3,5-dibromosalicylic acid (3. 776 g, 12.8 mmol) 
were dissolved in 40 to 50 ml of dried benzene to which were added 4 equivalents of 
N,N-dimethylaniline (3.213 ml, 25.3 mmol). To this stirred mixture at 0 °C, 1.1 
equivalents of sebacoyl chloride (l.502 ml, 7.04 mmol) were added dropwise and the 
mixture was stirred for 3 hours at room temperature. The mixture was poured into ice-
cold acid water ( 15 ml, 0.05 M HCl) to produce a white precipitate which was 
collected, dried, and recrystallized twice from a 50 : 50 hot acetone-water mixture. 
Purity of Synthesized Materials 
The purity of the synthesized samples was assessed by NMR spectroscopy and 
melting point. 1H and 13C NMR spectra were taken in deuterated dimethyl sulfoxide 
(DMSO) in 5 mm tubes with a Varian VXR-300 spectrometer. Melting points were 
determined on a Met-Temp melting point apparatus and were uncorrected. 
III. Molecular Modeling 
Modeling studies were carried out on a Indigo workstation. For graphics and 
structure building, the Insight II softwear package from Biosym, Inc. was used. The 
coordinates of oxy- and deoxyhemoglobin were obtained from the Protein Data Bank at 
Brookhaven National Laboratory. 
IV. Preparation of Hemoglobin 
Hemoglobin was prepared from packed red blood cells (RBC's), obtained from 
Life Source, following the procedure of Dozy et al. (82). The RBC's were washed with 
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phosphate buffer saline (PBS). 80 ml of ice cold PBS (150 mM NaCl in 5 mM 
phosphate buffer, pH 8.0) were added to 20 ml of the RBC's. The mixture was stirred 
gently for one minute and was centrifuged at 3000 rpm (1075 g) for 10 minutes with a 
Sorvall RC5B refrigerated superspeed centrifuged using a SS-34 rotor (Dupont). The 
supernatant and huffy coat were removed by aspiration. The washing of the RBC's with 
PBS was repeated two more times to ensure that the RBC 's were free of unwanted 
plasma materials. All these steps were performed at 4 °C. The washed erythrocytes were 
lysed in 40 ml of ice cold deionized water with gentle stirring for 30 minutes at 4 °C. 
20 ml of ice cold neutral ammonium sulfate (76.7 % NH4S04 , pH 7.0) was added to the 
solution and the mixture was stirred for another 30 minutes at 4 °C. Then the mixture 
was centrifuged at 12,000 rpm (17,210 g) for 10 minutes. The hemoglobin in the 
supernatant was collected and the precipitates containing the membranes and other 
residues were discarded. 
The hemolysate was desalted by dialysis in Tris buffer (0.05 M Tris, 1 mM 
NaCN, pH 8.5). The completion of desalting was checked by adding 1 M BaCl2 to the 
dialysis buffer solution to test whether or not BaS04 precipitate was able to form. After 
desalting was complete, the dialysate was ready for ion-exchange chromatography. 
Ion-exchange chromatography was performed according to methods of Huisman 
and Dozy (83), and Dozy et al. (82). DEAE-Sephadex A-50 was swollen in water. The 
column was packed with Sephadex gel and equilibrated with a buffer composed of 0.05 
M Tris, 1 mM NaCN, pH 8.5, at a flow rate of about 20 ml/hr in the refrigerator. 
When the pH of the eluent buffer reached 8.5, the dialyzed hemolysate was applied to 
31 
the column. Hemoglobin was purified with a linear pH gradient from 8.5 to 7.2 with 
0.05 M Tris, 1 mM NaCN. The elution was detected at 280 nm by a ISCO UA-5 
absorbance/fluorescence detector. 
V. Crosslinking Reactions of Hemoglobin 
Reaction of 1,5-Difluoro-2,4-Dinitrobenzene (DFDNB) with 
Hemoglobin 
The crosslinking reactions of hemoglobin with DFDNB were carried out in 0.01 
M MOPS, 1 mM NaCN, pH 7.0. The molar ratio of hemoglobin tetramer to DFDNB 
varied from 1: 1 to 1: 10. The hemoglobin concentration was kept at 1 mg/ml. The 
hemoglobin concentration was determined spectrophotometrically on a Hewlett-Packard 
8451 A UV/VIS diode array spectrophotometer by using EmM of 13.8 per heme at 542 
nm (84). DFDNB solution was prepared by dissolving DFDNB in distilled acetone in 
the dark at a concentration of 50 mg/ml. Freshly prepared DFDNB solution was slowly 
added to a gently stirred hemoglobin solution. The crosslinking reaction was carried out 
for a period up to 2 hours at room temperature. The reaction was stopped by addition 
of 0.1 volume of 1.0 M glycine/MOPS, pH 7.0. 
For the deoxy crosslinking reaction, the hemoglobin solution was purged with 
a slow stream of N2 gas in an ice bath for 2-4 hours until the solution appeared purplish. 
Freshly prepared DFDNB solution was purged with N2 gas for 10 minutes and slowly 
added to the deoxyhemoglobin solution while purging with N2 at room temperature. The 
remaining steps were the same as for the oxy crosslinking reaction. 
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After the reactions, the crosslinked hemoglobin solutions were dialyzed against 
large volumes of 0.05 M Tris, 1 mM NaCN, pH 8.5 and purified on a DEAE-Sephadex 
A-50 column with two linear gradients. The first pH linear gradient was 0.05 M Tris, 
1 mM NaCN, pH 8.5 to 7.0, and it was followed by a second salt (NaCl) linear gradient 
from 0 to 0.5 M of 0.05 M Tris, 1 mM NaCN, pH 7.0. 
Double Crosslinking Hemoglobin with 
Bis(3,5-Dibromosalicyl) Fumarate (DBSF) 
The crosslinking reaction with bis(3,5-dibromosalicyl) fumarate (DBSF) was 
carried out essentially according to the method of Walder et al. (38) for oxyhemoglobin 
and Chatterjee et al. (39) for deoxyhemoglobin. The molar ratio of hemoglobin tetramer 
to DBSF was kept at 1: 1.1 for all the experiments, regardless of the concentration of 
hemoglobin. The hemoglobin concentration was varied for some experiments from 0.01 
mM to 0.25 mM tetramers, but most experiments were done at 0.2 mM. 
The crosslinking reaction of oxyhemoglobin with DBSF was done by adding a 
known amount of DBSF to the oxyhemoglobin solution. The mixture was gently swirled 
every 30 minutes for a total of 2 hours at 37 °C. After 2 hours, the mixture was 
submerged in an ice bath for 20 minutes to terminate the reaction. The hemoglobin 
solution was dialyzed against 0.05 M Tris, 1 mM NaCN, pH 8.5 and purified by 
DEAE-Sephadex A-50 column chromatography with a linear gradient 0.05 M Tris, 1 
mM NaCN, pH 8.5 to 7.2. 
The purified crosslinked hemoglobin, named {382XLHbA, was dialyzed against 
0.01 M MOPS, pH 7.0 and further doubly crosslinked with DBSF in the deoxy 
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conditions. The /182XLHbA was purged with a slow stream of wet N2 gas in an ice bath 
for 1-4 hours until the solution appeared purplish. Then the solution was transferred to 
a water bath already equilibrated at 37 °C and to which the crosslinking reagent, DBSF, 
was added while purging with N2 • The solution was swirled every 30 minutes and 
incubated for a total of 2 hours. The reaction was terminated in a ice bath for 20 
minutes. The excess unreacted DBSF was removed by passage over a Sephadex G-25 
column equilibrated with 0.01 M MOPS, 1 mM NaCN, pH 7.0. Then the mixture was 
dialyzed in 50 mM Tris buffer, 1 mM NaCN, pH 8.0. 
The doubly crosslinked hemoglobin was purified on a DEAE Sephadex-A50 
column by using a linear pH gradient of 0.05 M Tris, 1 mM NaCN, pH 8.0 to 7.2. The 
major crosslinked species was dialyzed against 0.05 M Tris, 1 mM NaCN, pH 8.0 
buffer and rechromatographed by using a Pharmacia fast protein liquid chromatography 
(FPLC) system. The Mono Q HR 515 (5x0.5 cm I.D.) (anion exchange) column was 
used. Buffer A was 50 mM Tris, pH 8.0. Buffer B was 50 mM Tris, 0.5 M NaCl, pH 
8.0. Both buffers contained 1 mM NaCN. The buffer and the sample were filtered 
through a membrane filter with a 0.2 µM pore size. The flow-rate was 0.5 ml/minute 
and the eluent was monitored at 280 nm (85-86). The gradient was started with 100 % 
of buffer A for 5 minutes, then linearly changed to 100 % of buffer B in 60 minutes. 
Crosslinking a99XLHbA and /182XLHbA with DFDNB 
The crosslinking reactions of a99XLHbA and /182XLHbA with DFDNB were 
carried out in 0.1 M MOPS, pH 7.0 for 2 hours. The molar ratio of a99XLHbA and 
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~82XLHbA to DFDNB were 1: 10. Both reactions were carried out in oxy conditions. 
The yields of the doubly crosslinked reactions were determined by SDS-PAGE gel 
electrophoresis. The reaction mixtures were directly subjected to SDS-PAGE gel 
electrophoresis without further purification. 
Modification of Hemoglobin with Bis(3,5-Dibromosalicyl) Sebacate 
The reaction of hemoglobin with bis-3,5(dibromosalicyl) sebacate (DBSS) 
followed the method of the reaction of hemoglobin with DBSF described above (38). 
The molar ratio of hemoglobin tetramer to DBSS was kept at 1: 1.1. 
The crosslinked hemoglobin was purified first on a DEAE-Sephadex A-50 
column using 0.05 M Tris, 1 mM NaCN buffer from pH 8.5 to 7.0 to separate the 
uncrosslinked from modified hemoglobin. Then the crosslinked hemoglobin was 
rechromatographed on a FPLC system using the Mono Q HR 515 column. The buffer 
A was 50 mM Tris, pH 8.0 and the buffer B was 50 Tris, 0.2 M NaCl, pH 8.0. Both 
buffers contained 1 mM NaCN. The elution was carried out by using a gradient of 100 
% buffer A for 5 minutes and then a linear change to 100 % of buffer Bin 60 minutes 
at a flow rate of 0.5 ml/min. The column effluent was monitored by absorbance at 280 
nm. 
VI. Reduction Experiments 
The reduction experiments fllowed the method of Dixon et al. (57). The 
hemoglobin solution was dialyzed against 0.01 M MOPS, pH 7.6. The methemoglobin 
concentration was calculated by the method of Winterboum (87). The molar ratio of 
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methemoglobin to dithionite was 1 : 1.1. After dithionite was dissolved in 0.01 M 
MOPS, pH 7.6 under nitrogen gas, the solution was immediately applied to the 
Sephadex G-25 column which was equilibrated with 0.01 M MOPS, pH 7.6. Following 
the dithionite addition 2 ml of buffer were added, and then the hemoglobin solution was 
applied to the column. The methemoglobin was reduced when it passed through the 
dithionite layer. The concentrations of oxyhemoglobin and methemoglobin were 
calculated from the UV /VIS spectra by the method of Winterbourn (87). After the 
reduction experiments, the concentration of methemoglobin was lower than 4 % . 
VII. Concentrating Hemoglobin And Crosslinked Hemoglobin 
There were three ways used to concentrate hemoglobin and crosslinked 
hemoglobins. Large quantity samples were concentrated by a Pro-Dicon using Bio-
Molecular Dynamics Micro-Pro-Dicon membrane (MWCO : 10,000), or by 
ultrafiltration using Amicon PM-10 membrane. Small quantity samples were concentrated 
by centrifugation using Amicon Centricon (MWCO: 10,000). 
Concentrating by Using Pro-Dicon 
The hemoglobin fractions pooled under each peak of the chromatogram were 
collected and dialyzed in the appropriate buffer. Before the hemoglobin fractions were 
transferred to the dialysis tubes which were in the Pro-Dicon, the Pro-Dicon was 
vacuumed with a water aspirator for 30 minutes in an ice bath. Then the hemoglobin 
fractions were transfered to the dialysis tubes and the Pro-Dicon was kept under vacuum 
for at least another hour. Finally the Pro-Dicon was set in the refrigerator until the 
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hemoglobin was concentrated to the minimum volume allowed in the tubing. 
Concentrating by Using Ultrafiltration 
Ultrafiltration was carried out in the cold room under nitrogen gas, which was 
kept under 70 psi. The hemoglobin fraction solution was transferred into the 
ultrafiltration chamber and kept stirred during the procedure. Concentrating was stopped 
when the solution volume was less than 10 ml. 
Concentrating by Using Centrifugation 
Concentrating was carried out on a Sorvall RC5B refrigerated centrifuge using 
a SS-34 rotor. The dilute hemoglobin solution was added to the Centrcon tubes and 
centrifuged at 4000 rpm (1912 g) at 4 °C until the minimum volume allowed in the 
Centrcon tubes was reached. 
VIII. Preparation of Globin Chains 
The purification of globin chains followed the method of Ascoil et al. (88). 
Hemoglobin and crosslinked hemoglobin were dialyzed in excess deionized water to 
remove all the salt present in the solution. A 5 ml aliquot of hemoglobin solution (1 
mM per heme), cooled at 4 °C, was added dropwise and under vigorous stirring into 200 
ml of 2 % acid-acetone cooled at -20 °C. At the end of the addition, the acid-acetone was 
slightly brownish, and the globin precipitated as a white material. The suspension was 
centrifuged at 5000 rpm (2987g) in a centrifuge precooled at -20 °C. The heme-
containing supernatant was carefully removed by suction, and the precipitate, if colored, 
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was resuspended in acid-acetone cooled to -20 °C and separated again by centrifugation 
at the same temperature. The precipitate was washed 3 or 4 times with acetone in order 
to remove the acid. Then the precipitate was washed by ether and dried under nitrogen. 
The heme-removed globin chains were separated by ion-exchange 
chromatography on a CM-52 cellulose column. The starting buffer for chromatography 
was 8 M urea and 0.05 M 2-mercaptoethanol in 5 mM disodium phosphate. The final 
pH was adjusted to 6. 7 with H3P04 • The CM-52 column was equilibrated with starting 
buffer at a flow rate of 10 ml/h. In the starting buffer, 30-40 mg of globin were 
dissolved to a final concentration between 4 and 10 mg/ml. The globin solution was then 
absorbed on the column, which was washed with buffer for 30 minutes in order to 
remove any unbound material. The column was then eluted at a flow rate of 10 ml/h 
using a gradient obtained by mixing the starting buffer with 8 M urea and 0.05 M 2-
mercaptoethanol in 0.05 M disodium phosphate, adjusted to pH 6.7 with ~P04 • The 
separated globin chains were dialyzed against a large quantity of water to remove salt, 
urea and 2-mercaptoethanol and lyophilized by using a speed Vacuum Rota-Vapor 
(Savant Instruments, Inc.). 
IX. Amino Acid Composition Analysis 
Hydrolysis of the Samples 
Amino acid hydrolysis was carried out in the gas-phase by 6N HCl according 
to the procedures of Hughes and Frutiger (89). Lyophilized globin chains (0.05-3 µg) 
were added into sample tubes. The sample tubes and the tube which contained 6 N HCl 
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were placed into a vessel. The vessel was sealed and carefully evacuated. The apparatus 
was then placed immediately in a heating block at 110°C for 24 hours or at 155°C for 
1 hour. After the hydrolysis, the tubes were dried under vacuum prior to derivatization. 
Derivatization 
Precolumn derivatization of amino acid by phenylisothiocyanate (PITC) followed 
the procedure of Bidlingmeyer et al (90). Hydrolyzed samples and standards were added 
first to 20 µl ethanol/water/triethylamine (2:2: 1) and dried to remove any remaining 
acid. This step was repeated twice. The dried samples and standards were incubated for 
20 minutes at room temperature after addition of 20 µl of 
ethanol/triethylamine/water/PITC (7: 1: 1: 1) and dried. Then samples were washed twice 
with acetonitrile to remove any excess PITC. After diluting with 1 ml of HPLC-
equilibration buffer (60 mM NaAc with 1 mM EDTA, pH 5.5) the samples were filtered 
and were ready for HPLC separation. 
Amino Acid Analysis 
HPLC was performed by following modifications of the methods of Ebert (91), 
Gimeney-Gallego & Thomas (92) and Heinrikson & Meredith (93) at 40°C with a 
Hewlett-Packard (Analytic Instruments Avondale, PA) model 1090M analytic gradient 
HPLC system at Northwestern University with the following capabilities: binary 
programmable gradient solvent delivery module for standard and microbore columns, 
variable volume (0.1-250 µl) autoinjector, UV/vis (190-800 nm) diode-array detector, 
and LC Chemstation computer with software for data acquisition and analysis. The 
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stationary phase was a 4.6 X220 mm SPHERI-5 octadecylsilyl (ODS) reverse-phase 
column (particle size, 5µm). Solvent A was 60 mM sodium acetate, 1 mM EDTA, pH 
5.5. Solvent B consisted of 30% of solvent A and 70% of acetonitrile. The gradient run 
from 12 to 20% of B in 4 minutes, then to 32 % of B in 6 minutes, and then to 60% of 
Bin 10 minutes and stayed at 60% of B for another 10 minutes at a flow rate of 1.0 
ml/min. The effluent was monitored at 254 nm. 
The number of amino acids was estimated first by multiplying the average 
number of residues, 140.5, by the area ratio of the individual amino acid to the total 
area of all residues from the a and f3 chains. The a-chain has 141 residues and the {3-
chain has 146 residues. The average residue is calculated as shown below: 
Average Residue = (141 + 146 -6)/2 = 140.5 
The subtraction of 6 was due to the three tryptophan and 3 cysteine residues per 
af3 dimer. After the amino acid residue of each globin chains was determined by using 
the average residue, the real amino acid residues of a and {3 chains were recalculated 
by using 139 and 142 residues for a and f3 chains, respectively, since the at chain has 
1 tryptophan and 1 cysteine and the {3 chain has 2 tryptophans and 2 cysteines. 
a chain residue = 141 - 2 = 139 
{3 chain residue = 146 - 4 = 142 
X. Peptide Mapping 
Trypsin Digestion 
Trypsin digestion followed the method of Kluger et al. (41). Globin chains were 
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first dissolved in 8 M urea (to increase susceptibility to digestion) and kept at room 
temperature for 2-4 hours. The solution was then diluted to 2 M urea with 80 mM 
ammonium bicarbonate buffer, pH 8.5. Trypsin (2 % of total protein) was added, and 
the solution was digested for 24 hours at room temperature. The tryptic peptides were 
then heated in boiling water for 2 minutes, diluted to 1 M urea with 80 mM ammonium 
bicarbonate buffer and filtered through a 0.2 µM filter before injection onto the HPLC 
column. 
Tryptic Peptide Separation 
Tryptic peptides were separated by reverse-phase HPLC on a C18 large-pore 
column following a modification method of Shelton et al (94). The gradient between 
0.1 % trifluoroacetic acid (TFA) (A) and 0.1 % TFA in acetonitrile (B) ran from 0 to 
13.6% Bin 20 minutes, then to 34% Bin 50 minutes, to 60% of Bin 20 minutes, and 
then to 100% of B in 10 minutes at a flow rate of 1 ml/min. The column effluent was 
monitored by absorbance at 214 nm. 
XI. Electrophoresis 
Sodium Dodecylsulfate Polyacrylamide Electrophoresis 
The SDS-PAGE gel electrophoresis was carried out on a Pharmacia PHAST gel 
apparatus. 12.5 % of homogeneous gel (12.5 % T, 2 % C) and SDS buffer strips 
(Pharmacia Co.) were used. The samples were denatured for 5 minutes at 100°C in 10 
µl of a solution made of 0.25 M Tris, pH 6.8, 4% SDS, 20% glycerol, 10% {3-
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mercaptoethanol, and 0.05% bromophenol blue as the marker dye. Two sets of 
molecular weight standard markers were used, one with 7 proteins and 6 for another. 
The 7 protein molecular standard markers were bovine albumin (66,000 daltons), egg 
albumin (45,000 daltons), glyceraldehyde-3-phosphate dehydrogenase (29,000 daltons), 
carbonic anhydrase (24,000 daltons), trypsin inhibitor (20,100 daltons) and a-lactalbumin 
(14,200 daltons). The other set of protein standard markers were phosphorylase b 
(94,000 daltons), bovine serum albumin (67,000 daltons), ovalbumin (43,000 daltons), 
carbonic anhydrase (30,000 daltons), soybean trypsin inhibitor (21,100 daltons) and a-
lactalbumin (14,400 daltons). The molecular protein standard markers were treated in 
the same digestion mixture as the samples. Electrophoresis was carried at a constant 
current of 10 mA (250 V until the marked dye reached the bottom of the gel. After the 
electrophoresis, the proteins were fixed and stained by soaking the gel in 0.1 % PhastGel 
blue R solution in 30% methanol and 10% acetic acid in distilled water for 5 minutes. 
The gel was detained in the same solution excluding the blue R stain for 20 minutes 
twice. The molecular weights of the crosslinked hemoglobin were estimated from the 
graph of the log of molecular weight versus relative mobility of the standard markers. 
The SDS-PAGE gels were scanned on a ISCO gel scanner (model 1312). The percentage 
of crosslinking can be calculated by using the gel scanning program ISCO on a IBM 
computer. 
Alkaline Agarose Electrophoresis 
Alkaline agarose gels were commercially prepared by Ciba-Corning (95). The 
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alkaline agarose gel consists of 1 % agarose, 0.053 M Tris, 0.002 M EDTA and 0.0059 
M boric acid, pH 8.6. The electrophoresis apparatus (Coming Medical) was used. 
Electrophoresis was performed at 240 volts for 20 minutes in an alkaline hemoglobin 
buffer (16.7 g sodium barbital and 2.5 g barbital in 2 L of deionized water, pH 8.6). 
The gel was fixed and stained with Amido Black lOB stain solution (1. 7 g Amido Black 
lOB in 1 L of 5 % acetic acid) for 10 minutes and transferred to the first 5 % acetic 
acid clearing solution for 30 seconds. After the moisture on the back of the gel was 
wiped off, the gel was dried in an oven at 65 °C. The gel was removed from the oven 
and allowed to cool to room temperature, the gel was rinsed in the first 5 % acetic acid 
clearing solution for about 1 minute with agitation, then the gel was transferred to the 
second 5 % acetic acid clearing solution and rinsed again until all excess stain was 
removed. Finally the gel was rinsed with deionized water for 2 minutes and dried in the 
oven. 
XII. Denaturation Experiments 
The thermal denaturation experiments were done by the methods of White & 
Olsen (96) and Yang & Olsen (46) on a Hewelett-Packard 8451A UV/VIS diode array 
spectrophotometer, which included a HP-7470A plotter, a HP-1921 disc drive, a 
NESLAB endocal refrigerated circulation bath RTE-9, a NESLAB temperature 
programmer ETP-3, a NESLAB digital controller/readout DCR-4, and an Omega 
temperature indicator. The solvent was O.OlM MOPS, pH 7.0, containing 0.9 M 
guanidine to keep the hemoglobin from precipitating after denaturation had occurred. 
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Hemoglobin is not denatured at room temperature by this concentration of guanidine. 
However, this do not mean that guanidine does not have an effect. The denaturation 
temperature measured in the presence of guanidine is lower than the precipitaion 
temperature measured in its absence. For this reason, it is essential to run a control 
using normal Hb A with every set of experiments. The hemoglobin concentration in the 
denaturation experiment was kept constant at 7 µM per heme. The hemoglobin and 
crosslinked hemoglobin were first oxidized to methemoglobin by 9. 7 x 1 o-3mM potassium 
ferricyanide for 15 minutes. The oxidation was monitored by observing the shift in the 
Soret band absorbance peak using a Hewlett-Packard 8451A diode array 
spectrophotometer. 
A movable seven cuvettes holder in the spectrophotometer was used. Seven 
cuvettes were used in each experiment (one was the reference and six were hemoglobin 
samples). The program for this denaturation experiment was written to take a 
measurement of each sample in 15 second intervals. The time interval between the same 
sample was 1. 75 minutes. For each round of measurements, the reference which 
contained 9. 7 µM potassium ferricyanide was taken prior to measurement of the 
samples. The wavelengths used monitor the denaturation were 280 nm, 406 nm, 418 
nm, 522 nm, 540 nm, 576 nm and 630 nm. The wavelength used for baseline correction 
was 410 nm. Seven entire spectra were taken from 200 - 650 nm in every 14 °C interval 
for observation of the base line shift. A programmable Neslab water circulator controlled 
the temperature in the cuvette. A heating rate of 0.3 °C/min was used from 25 to 70 °C 
or from 30 to 75 °C. The temperature were recorded for each spectrum using an Omega 
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thermocouple. The denaturation experiments lasted approximately 3.5 h. 
The denaturation data were analyzed by the first derivative method (96). The 
first derivative of the absorbance with respect to temperature was calculated and plotted 
as a function of temperature. The maxima and minima of these plots correspond to the 
temperatures at which the absorbance is changing most rapidly. These temperatures are 
defined as the denaturation temperatures (T j. In order to eliminate a slight variation 
in heating rate, solvent composition, pH, or spectrophotometer performance, the 
differences in denaturation temperature between the samples and control hemoglobin 
( t:.. T j were reported. 
XIII. Oxygen Binding Experiments 
The oxygen binding curves were determined with a Hemox analyzer (TCS 
Medical Products) in 4 ml of Hemox-solution (0.05 M phosphate buffer with 135 mM 
KCl, pH 7.4), and 10 µl anti-foaming agent. The hemoglobin concentration was kept 
higher than 55 µM per heme and the methemoglobin concentration was lower than 6 % 
of the total hemoglobin. The experiments were carried out at pH 7.4 and 37 °C to 
simulate physiological conditions. Both air and nitrogen gas cylinders were adjusted so 
that the outlet pressures remained constant at 10 psi. 
The oxygen binding curves of % oxyhemoglobin vs. oxygen partial pressure 
were plotted automatically. The P 50 and Hill coefficient values were calculated from the 
oxygen binding curves by using the Hill equation. 
y p02 
log 
---------
= n log 
---------
1-Y Pso 
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The measurements of the oxygen equilibria studies were plotted according to 
the Hill equation with log YI 1-Y on the ordinate and log p02 on the abscissa; linear 
plots would be expected. The x intercept of this line at Y = 0.5 gives the P so value. The 
slope of this line, n, is a measure of subunit cooperativity. 
XIV. Autoxidation Experiments 
The autoxidation experiments were carried out in 0.01 M MOPS, pH 7.4, at 
37 °C. The spectra from 500 to 700 nm were recorded every 30 minutes for a total of 
17 hr. The concentrations of native hemoglobin and crosslinked hemoglobin were kept 
at 68.5 µM per heme and the methemoglobin concentrations were kept lower than 6% 
by using freshly prepared samples. 
If methemoglobin is the only product of autoxidation, the autoxidation can be 
followed by monitoring absorbances at 576 and 630 nm. From the extinction coefficients 
of hemoglobin derivatives (Table 2), the oxyhemoglobin and methemoglobin 
concentrations in µM can be calculated according to the following equations. 
[Oxyhemoglobin] = 66 A576 - 80 A630 
[Methemoglobin] = 279 A630 - 3.0 A576 
The sum of these concentrations should remain constant during the course of 
the autoxidation. 
However in many instances the autoxidation reaction is more complex. Besides 
methemoglobin, there were hemichromes and sometimes choleglobin present. Therefore 
more wavelengths must be monitored. The hemoglobin product with a free radical, 
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choleglobin, had an increase in absorbance at 700 nm. So the absorbances of the solution 
at 560, 576, 630 and 700 nm were measured at first. Then the A100 value was subtracted 
from each of the other absorbances as the contribution of choleglobin. Finally the 
micromolar concentration of the oxyhemoglobin, methemoglobin and hemichrome were 
calculated from the absorbances using the following equations, which are derived from 
the extinction coefficients given in Table 2 (87) 
[Oxyhemoglobin] = 119 A576 -39 AO!IJ - 89 A500 
[Methemoglobin] = 28 A576 + 307 AO!IJ - 55 A500 
[Hemichrome] = -133 A576 - 114 AO!IJ + 233 A500 
The natural logarithm of the concentrations of oxyhemoglobin vs. time were 
plotted and the apparent rate constants were computed. All data presented are the 
average of 5 or more independent experiments, with the error reported as the standard 
deviation of the rate constants for independent measurements. 
Table 2 
Millimolar Extinction Coefficients of Hemoglobin Derivatives 
Samples 
Oxyhemoglobin 
Methemoglobin 
Hemichrome 
460 
8.6 
4.30 
8.6 
Wavelenghth (nm) 
576 
15.0 
4.45 
6.8 
Values are all expressed per heme group (87). 
630 
0.17 
3.63 
0.92 
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CHAPTER III 
RESULTS 
I. Syntheses 
Synthesis of Bis(3,5-dibromosalicyl) Fumarate 
The bis(3,5-dibromosalicyl) fumarate was a white powder with a melting point 
of 226.5-227.5 °C. The 1H and 13C NMR spectra of bis(3,5-dibromosalicyl) fumarate in 
DMSO and the presumed structure are shown in Figures 4A and 4B. The four 
resonances from 1H NMR spectrum are matching the four protons on the half of the 
molecule. The integration of the resonances at 7.34, 8.08-8.09 and 8.33-8.34 ppm 
indicated a ratio of 2: 1: 1 which agrees with the ratio of the two fumaryl protons to the 
two phenyl protons of the presumed structure of DBSF. The 13C spectrum shows nine 
resonances which match the nine identical carbons on the half of DBSF molecule. 
Synthesis of Bis(3,5-dibromosalicyl) Sebacate 
The bis(3,5-dibromosalicyl) sebacate (DBSS) was a white powder with a melting 
point of 166.0-167.0 °C. Figures 5A and 5B show the 13C and 1H NMR spectra of 
bis(3,5-dibromosalicyl) sebacate in DMSO and acetone and its presumed structure. 
The integration of the 1H NMR resonances at 8.115-8.135, 2.629-2.676, 1.726-
1. 777 and 1.392-1.440 ppm indicated a ratio of 2:2:2:4 which agrees with the proton 
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Fig. 4A. 1H NMR spectrum of bis(3,5-dibromosalicyl) fumarate (DBSF) in deuterated 
DMSO and its presumed structure. 
Fig. 4B. 13C NMR spectrum of bis(3,5-dibromosalicyl) fumarate in deuterated DMSO. 
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ratio of the presumed structure of DBSS. 
The 13C NMR spectrum shows twelve resonances which agree the twelve 
identical carbons on half of the molecule of DBSS. 
II. Purification of Hemoglobin 
The purification of hemoglobin A from the minor hemoglobins and other red 
cell components was achieved by anion-exchange Sephadex A-50 chromatography using 
a linear gradient from pH 8.5 to 7.2. The chromatogram of purification of hemoglobin 
A from a hemolysate obtained from packed blood cells resulted in the elution of four 
peaks absorbing at 280 nm (Figure 6). Peak III is the major component. The four 
protein fractions under each peak were analyzed on alkaline agarose gel electrophoresi 
(Figure 7) to identify the proteins and check for contaminants. The protein fractions 
from peak I, II and IV were concentrated before subjecting them to the alkaline agarose 
gel electrophoresis. The peak II and peak III show very sharp single bands and peak I 
sometimes shows two bands, one main band and one minor band. The minor band was 
very light and usually could only be seen on the original gel. This is why on the Fig. 
7 there was only one band for peak I. The peak IV has a broad band which means it 
may contain several species. The mobility of these proteins on alkaline agarose gels was 
in the opposite order of that eluted from the A-50 column, as expected. The largest 
peak III was identified as Hb A by comparison of its mobility with a standard Hb A 
sample. Peaks II and IV contained Hb A2 and Hb A1c (or glycosylated Hb A). The very 
small peak I was probably due to other red cell proteins. 
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Fig. 5A. 13C NMR spectrum of bis(3,5-dibromosalicyl) sebacate in deuterated DMSO 
and its presumed structure. 
Fig. 5B. 1H NMR spectrum of bis(3,5-dibromosalicyl) sebacate in deuterated acetone. 
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III. Double Crosslinking Hemoglobin with 
Bis(3.5-DibromosalicylL) Fumarate (DBSF) 
Purification of the products from the double crosslinking reaction 
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The Hb A (peak III) from the above purification was used to do all of the 
crosslinking reactions. The mixtures of Hb A reacted with bis(3 ,5-dibromosalicyl) 
fumarate under oxy and deoxy state conditions were separated on anion-exchange 
Sephadex A-50 column (Figure 8A and 8B). Peaks II from both chromatograms are the 
designed product, e82XLHbA and a99XLHbA. The first peaks from both separation 
chromatograms are uncrosslinked hemoglobin. The third peak from the deoxy 
crosslinking condition contained at least one species that was crosslinked between the 
two e chains (48). However, what exact amino acids were crosslinked is still unknown. 
Both a99XLHbA and e82XLHbA show a single sharp band on the alkaline agarose gel 
electrophoresis (Fig. 9). This result demonstrates that both a99XLHbA and e82XLHbA 
have been successfully purified from contamination by the Sephadex A-50 column. 
The purified e82XLHbA was further treated with DBSF under deoxy 
conditions. The double crosslinked hemoglobin mixture was separated on anion exchange 
DEAE-Sephadex A-50 with the pH gradient from 8.0 to 7.2 (Fig. lOA) followed 
rechromatography of the major zone isolated from the DEAE-Sephadex A-50 column 
(Zone 2, Figure lOA) on a FPLC system using a Mono Q column. The chromatogram 
gives one major component and several minor components (Figure lOB). This major 
component is the desired product, e,a-XLHbA. 
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Fig. 6. Elution chromatogram of hemoglobin A on a DEAE-Sephadex A-50 column. 
Buffer A: 0.05 M Tris, 1 mM NaCN, pH 8.5. Buffer B: 0.05 M Tris, 1 mM NaCN, 
pH 7.2. The flow rate was 15 ml/h. Absorbance was detected at 280 nm. The trace 
shown was not started until the hemoglobin was near the bottom of the column. Peak 
I is unknown protein; peak II is Hb A2 ; peak III is Hb A; and peak IV is Hb A1c. 
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Fig. 7. Alkaline agarose gel electrophoresis data of hemoglobin compounds. Line 1 
is hemoglobin standard, lane 2 is unknown protein (Fig. 6, peak I), lane 3 is Rb A2 
(Fig. 6, peak II), lane 4 is Hb A (Fig. 6, peak III), and lane 5 is Hb A1c or glycosylated 
Hb A (Fig. 6, peak IV). 
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Fig. SA. A-50 anion-exchange chromatography of reaction products between DBSF 
and oxyhemoglobin. Gradient elution at flow rate of 15 ml/h was used. Buffer A 
consisted of 0.05 M Tris, 1 mM NaCN, pH S.5. Buffer B consisted 0.05 M Tris, 1 mM 
NaCN, pH 7.2. Absorbance was detected at 2SO nm. The trace shown was not started 
until the hemoglobin was near the bottom of the column. 
Fig. SB. A-50 anion-exchange chromatography of reaction products between DBSF and 
deoxyhemoglobin. Buffer A was 0.05 M Tris, 1 mM NaCN, pH S.5 and buffer B was 
0.05 M Tris, 1 mM NaCN, pH 7.2. Flow rate was 15 ml/h. Absorbance was detected 
at 2SO nm. The trace shown was not started until the hemoglobin was near the bottom 
of the column. 
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Results of Electrophoresis 
The purity of /3,a-XLHbA after this purification was checked on alkaline 
agarose gel electrophoresis (Figure 9). On the alkaline agarose gel, /3,a-XLHbA had one 
single band indicating it was sucessfully purified by FPLC system. It moved faster than 
a99XLHbA and {382XLHbA toward the higher pH region indicating the net charge of 
{j,a-XLHbA was lower than a99XLHbA and {j82XLHbA. The a99XLHbA and 
{382XLHbA had essentially the same mobility and moved faster than Hb A. The subunit 
molecular weight of /3,a-XLHbA was estimated by comparison of mobilities with those 
of the standard proteins electrophoresed in different lanes on the same SDS-PAGE gel 
(Fig.11). The double crosslinking reaction of {382XLHbA by DBSF yield predominantly 
two dimer band (Mr 32,000) and a small fraction of monomer band (M, 16,000). The 
SDS scan result shows that the amount of the two dimeric species was about 95 % of 
the total protein (Table 3). Since {382XLHbA already contributed 50 % of the total 
protein as dimers due to its Lys 82{31 to Lys 82132 crosslinking, this 95 % dimer result 
indicated that the second modification reaction, caused about 45 % of inter chain 
crosslinking between the two a chains, just as we expected. 
Oxygen Binding Results of Hemoglobin Single and Double Crosslinked by DBSF 
As we know only the reduced form of hemoglobin can bind oxygen reversibly. 
When hemoglobin is oxidized to methemoglobin it no longer has this function. 
Therefore, in all samples which were used for oxygen binding experiments the 
methemoglobin concentration was kept as low as possible. Prior to oxygen binding 
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Fig. 9. Alkaline agarose gel electrophoresis data of HbA, and of singly and doubly 
crosslinked hemoglobin. Lane 1 is HbA; lane 2 is a99XLHbA; lane 3 is ,B82XLHbA 
and lane 4 is /1,a-XLHbA. 
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Fig. lOA. Separation of double crosslinked hemoglobin derivatives on a Sephadex A-
50 column. Buffer A: 0.05 M Tris, 1 mM NaCN, pH 8.0. Buffer B: 0.05 M Tris, 1 
mM NaCN, pH 7.2. Flow rate was 15 ml/h. The absorbance was detected at 280 nm. 
The trace shown was not started until the hemoglobin was near the bottom of column. 
Fig. lOB. Rechromatography of peak II of figure 10 a on FPLC system by using a 
mono Q column. The flow rate was 0.5 ml/min. Buffer A: 50 mM Tris, 1 mM NaCN, 
pH 8.0. Buffer B: 50 mM Tris, 0.5 M NaCl, 1 mM NaCN, pH 8.0. The elution was 
done using buffer A for 5 minutes and then gradually increasing buffer B to 100 % in 
60 minutes at a flow rate of 0.5 ml /min. The effluent was monitored by absorbance at 
280 nm. 
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Fig. 11. SDS gel electrophoresis data of singly and doubly crosslinked hemoglobins. 
Line 4 contains a standard mixture of marker proteins. The marker proteins used are: 
bovine serum albumin (M, 66K), egg albumin (M, 45K), glyceraldehyde-3-phosphate 
dehydrogenase (M, 36K), carbonic anhydrase (M, 29K), trypsinogen (Mr 24K), trypsin 
inhibitor (M, 20.lK) and a-lactalbumin (M, 14.2K). Lane 1and5 are JS,aXLHbA; Lane 
2 and 6 are J382XLHbA; lane 3 and 7 are a99XLHbA, and lane 8 is HbA. 
-- ..a. 
--
... 
-......_~----· 
1 2 3 
-
-
-
--.. 
-
4 
69 
_ ....... 
._ .. _ ...,../" 
5 6 7 8 
70 
experiments all the samples were concentrated and the oxyhemoglobin percentage was 
measured. If the oxyhemoglobin percentage was lower than 94 % , the sample was 
reduced with sodium hydrosulfite. Figure 12 shows the spectra of /3,a-XLHbA before 
and after reduction. Before reduction the methemoglobin percentage was about 10 % . 
After reduction the methemoglobin percentage was reduced to 1. 6 % • 
The oxygen equilibrium curve of native hemoglobin, crosslinked hemoglobins 
and RBC were measured in 0.05 M phosphate buffer, in the presence of 135 mM KCl, 
pH 7.4, at 37 °C (Figure 13A). In some experiments IHP were added at a ratio of 1: 1 
to hemoglobin tetramer. The Hill plot of the curves are presented in Figure 13B, for 
The relevant parameters are summarized in Table 4. Without IHP present, the oxygen 
binding curves of /3,a-XLHbA and a99XLHbA were almost superimposed. The P50 of 
/3,a-XLHbA was about 14.8 mmHg which was similar to the P50 value of a-99XLHbA, 
14.9 mmHg, and higher than the P50 values of /3-82XLHbA and Hb A, 7.4 and 9.6 
mmHg, respectively. Unlike Hb A, the P50 value of /3,a-XLHbA is insensitive to IHP, 
consistent with the fact that the binding site of BPG (therefore, also of IHP) is occupied 
by the crosslinker, DBSF. The nmax of /),a-XLHbA is about 2.4 without IHP present. 
When IHP is present, the nmax is still about 2.3. This indicated that the oxygen binding 
of /3,a-XLHbA remained highly cooperative and that the cooperativity was not affected 
by the presence of IHP. 
The reaction of bis(3,5-dibromosalicyl) fumarate with deoxy hemoglobin 
resulted in three peaks in the anion-exchange chromatography (Fig. 8A). The third peak 
was reported to contain crosslinks between the two /3 chains and was named as 
Table 3 
SDS-PAGE Gel Results of Hemoglobin Singly and Doubly Crosslinked by 
Bis(3,5-Dibromosalicyl) Fumarate 
Hemoglobin 
HbA 
J382XLHbA 
/3,cx-XLHbA 
Monomer 
100 % 
48.5 % 
5.2 % 
Dimer 
51.2 % 
94.8 % 
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Fig. 12. Visible spectra of ,B,a-XLHbA before (_ _ _) and after( __ ) reduction. 
native Hb A, ,B82XLHbA, a99XLHbA, ,B,a-XLHbA and RBC. 
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Fig. 13A. Effect of crosslinking on the oxygen equilibrium curve of hemoglobin A and 
DBSF-crosslinked crosslinked hemoglobin. The oxygen binding experiments were carried 
out in 0.05 M phosphate buffer, 135 mM NaCl, pH 7.4, at 37 °C. From left to right the 
curves are {382XLHbA, Hb A, {3,aXLHbA, a99XLHbA and RBC. 
Fig. 13B. Hill plots of HbA, single and double crosslinked hemoglobin, and RBC. Hb 
A(+); a99XLHbA (.e.); {382XLHbA (0); {J,a-XLHbA (<>), RBC (X). 
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/3/3XLHbA (48). Figure 14A and 14B show the oxygen binding curves and Hill plots of 
/3/3XLHbA with or without IHP. The oxygen binding curves and n values were not 
affected by the presence of IHP indicating that the BPG binding sites were blocked by 
DBSF. The P50 value of /3/3XLHbA (14.4 mmHg) was very close to that of a99XLHbA, 
but n value of /3/3XLHbA was decreased (Table 4). 
Thermal Stability of Crosslinked Hemoglobin 
The thermal stabilities of native Hb A, singly crosslinked hemoglobin 
(a99XLHbA and /382XLHbA) and doubly crosslinked hemoglobin (.B,o:-XLHbA) were 
determined by denaturation experiments. Figure 15 shows the plot of the first derivative 
of the absorbance at 406 nm with respect to temperature for Hb A, /382XLHbA, 
o:99XLHbA and /3, o:XLHbA. Table 5 shows the Tm and ti.Tm values obtained from 
Figure 15. The temperature transition of /3,o:XLHbA spans from 48-66 °C. The 
minimum thermal denaturation temperature (Tj was about 61.0°C which was about 20.0 
°C higher than native Hb A and about 4.2-4.4 °C higher than both a99XLHbA and 
/382XLHbA. Thus, the thermal stability of double crosslinked product was significatly 
higher than that of native hemoglobin but only slightly higher than those of either single 
crosslinked hemoglobins. 
Autoxidation Rate of Double Crosslinked Hemoglobin 
The color of hemoglobin A is one of its most appealing properties. Most 
chemical reactions involving the heme group cause a detectable change in the visible 
absorbance spectrum of Hemoglobin A. These include not only the reversible binding 
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Fig. 14A. Oxygen binding curves of /3/3XLHbA and Hb A. The experiments were 
carried out in 0.05 M phosphate buffer, 135 mM NaCl, pH 7.4, at 37 "C. /3/3XLHbA 
(curve A); Hb A (curve B). 
Fig. 14B. Hill plots of /3/3XLHbA and Hb A. ( +) is /3/3XLHbA, (0) is Rb A. 
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Table 4 
Hill Coefficients (n) and P~ (mmHg) Values of 
Bis(3 ,5-Dibromosalicyl) Fumarate Crosslinked Hemoglobins 
HbA 
Hb A 
{j82XLHbA 
a99XLHbA 
{j,aXLHbA 
RBC 
{j{jXLHbA 
p • 
~ 
9.6±0.3 
7.4±0.2 
14.9±0.l 
14.8±0.4 
27.1 ±0.4 
14.4±0.4 
• n 
2.4±1.1 
2.4±0.1 
2.2±0.1 
2.4±0.1 
2.4±0.1 
1.8±0.6 
* -- No inositol hexaphosphate present 
# -- Inositol hexaphosphate present, IHP : Hb A1.etr = 1 : 1 
p II 
~ 
26.1±0.4 
7.2±0.1 
27.5±0.3 
14.6±0.3 
14.4±0.4 
79 
2.4±0.1 
2.4±0.1 
2.2±0.1 
2.3±0.1 
1.8±0.5 
of ligands, such as oxygen and carbon monoxide, to the heme but also the oxidation and 
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of ligands, such as oxygen and carbon monoxide, to the heme but also the oxidation and 
reduction of the heme iron. Therefore, the autoxidation can be detected by the changes 
in the visible spectrum of hemoglobin. Figure 16 shows the spectral changes of {3,a-
XLHbA at 37 °C in the visible range 500-700 nm with the time. This visible range was 
chosen as it demonstrates all the oxidation products of hemoglobin (i.e., metHbA, 
hemichrome and choleglobin). The spectra were obtained at 2 h intervals. With time the 
UV absorption of oxy{3,aXLHbA at 576 nm decreased and the met{3,a-XLHbA 
absorption at 630 nm increased. The formation of hemichrome is illustrated by the 
absorption at 560 nm. Choleglobin formation is suggested by the increase in absorption 
at 700 nm. Although several chromophores were simultaneously present, a single set of 
isosbestic points at 530 and 590 nm was observed (Fig. 16). This would be the case if 
a complex mixture of different hemoglobin oxidation products were formed in a constant 
proportion. A similar pattern of oxidation and a single set of isosbestic points has been 
found with native human hemoglobin. The oxyhemoglobin, methemoglobin and 
hemichrome concentration were calculated according to the method described by 
Winterbourn, as described above (87). Figure 17 shows the plots of Ln [OxyHb A] vs. 
time. The lines are almost linear. The autoxidation rates were calculated from the slope 
of the lines based on the linear relationships. 
The autoxidation rates of single and double crosslinked hemoglobins are listed 
in Table 6. The double crosslinked hemoglobin, {3,aXLHbA, had a autoxidation rate k..PP 
value about 4.17x10-2 h-1 which was about 1.4 fold slower than a99XLHbA and very 
close to Hb A and {382XLHbA. 
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Fig. 15. First derivatives of the absorbance at 406 nm with respect to temperature for 
Hb A (- -), a99XLHbA (----), ,B82XLHbA (--)and ,B,a-XLHbA (--). 
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Table 5 
Tm and ~Tm Values of Bis(3,5-Dibromosalicyl) Fumarate 
Crosslinked Hemoglobin at 406 nm 
Tm (°C) 
41.2 ± 0.80 
56.6 ± 0.96 
56.8 ± 0.34 
61.0 ± 0.42 
0 
15.4 
15.6 
19.8 
Tm -- the maximum denaturation transition temperature 
83 
a Tm -- difference in the T rn for the modified hemoglobin samples and the control Hb A 
run at same time 
84 
Fig. 16. Spectral changes of /J,a-XLHbA in 0.01 M MOPS, pH 7.4, at 37°C in the 
visible range of 500-700 nm with time. Each spectrum represents a recording obtained 
at 2 hour intervals. 
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Fig. 17. First-order plots for the autoxidation of HbA (0), fj82XLHBA(.6), 
a99XLHBA ( +), and /), a-XLHbA ( <>) with time. The autoxidation experiments were 
carried out in 0.01 M MOPS, pH 7.4, at 37 °C. 
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Table 6 
Comparison of k,.PP (h-1) and Relative Rate Constant Values for Autoxidation of 
Hb A and Modified Hb A, Assuming First Order Rate of Autoxidation 
Hb A 
HbA 
/382XLHbA 
a99XLHbA 
/3,aXLHbA 
4.06±0.37 
4.57±0.32 
5.61±0.28 
4.17±0.33 
k.e1 
1.00 
1.13 
1.38 
1.03 
r 
0.998+0.011 
0.997±0.015 
0.998±0.014 
0.999±0.015 
IV. Crosslinking Hemoglobin with 1.5-Difluoro-2.4-
Dinitrobenzene 
Crosslinking and Purification of Crosslinked Hemoglobins 
89 
The modifications of Hb A with 1,5-difluoro-2,4-dinitrobenzene (DFDNB) were 
carried out in 0.01 M MOPS, pH 7.0, at room temperature. The molar ratio of DFDNB 
to hemoglobin tetramer varied from 1: 1 to 10: 1. The products of the crosslinking 
reaction were subjected to SDS-PAGE electrophoresis to estimate the yield. The relative 
percentage of all the inter-chain crosslinking reactions are shown in Table 7. The yield 
of inter-chain crosslinking reactions depended on the molar ratio of crosslinking reagent 
to hemoglobin tetramer. When the crosslinking reactions were done at a ratio of 
hemoglobin tetramer to DFDNB lower than 1 : 8, the reaction yield of inter-chain 
crosslinking was very low. The products show a main band at the position of the native 
Hb A monomer (16,000 dalton) on the SDS-PAGE gel. The denaturation temperature 
(T ,J remained very close to that of native Hb A (Table 8) which fully agreed with the 
SDS-PAGE electrophoresis results which indicated that most hemoglobin was not 
crosslinked between subunits under these reaction conditions. When the ratio of 
hemoglobin tetramer to DFDNB was increased to over 1 : 8, the SDS-PAGE gel 
showed, in addition to a band running in the position of native Hb A monomer, a band 
appeared in the DFDNB-XLHbA products which migrated in the position of a dimer, 
indicating the occurrence of a covalent intersubunit crosslinking. 
The proteins crosslinked with a 10: 1 molar ratio of DFDNB to hemoglobin 
tetramer, were purified by anion-exchange DEAE-Sephadex A-50 column as described 
90 
Table 7 
SDS-PAGE Gel Electrophoresis Results of DFDNB Crosslinked Hemoglobin 
Hb A/DFDNB Monomer Dimer 
1:1 100% 0% 
1:2 100% 0% 
1:3 88.2% 11.8% 
1:4 85.2% 14.8% 
1:5 84.5% 15.5% 
1:8 64.8% 35.2% 
1:10 59.6% 40.4% 
The crosslinking reaction was carried out at 0.01 M MOPS, 1 mM NaCN, pH 
7.0. The concentration of Hb A was kept at 1 mg/ml. The ratio of the crosslinking 
reagent DFDNB to Hb Awtr was varied from 1: 1 to 10: l. 
Hb A/DFDNB 
1:1 
1:2 
1:3 
1:4 
1:5 
1:8 
1:10 
Table 8 
Effect of the HbA/DFDNB Ratio on the Thermal Stability of 
DFDNB Crosslinked Hemoglobin 
40.8 0 
40.8 0 
40.8 0 
40.8 0 
40.8 0 
46.0, 59.3 5.2, 18.5 
46.6, 60.2 5.8, 19.4 
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All the samples were crude reaction mixtures without purification. The native 
hemoglobin was run at same time as a standard which had a thermal denaturation 
temperature at 40.8 °C. 
* The denaturation temperature difference between native hemoglobin and 
modified hemoglobin 
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under "Material and Methods". Figure 18A and 18B show the chromatograms of 
hemoglobin crosslinked with DFDNB under oxy and deoxy conditions. Despite the 
different crosslinking condition, both reaction mixtures showed two peaks. The first peak 
from both reactions eluted during the pH gradient whereas the second peak eluted when 
the salt gradient was applied. These results suggest that the PI value of the second peaks 
were lower than 7. 0. 
Electrophoresis Results 
Purity of the two peaks from both Figure 18A and 18B were checked 
on alkaline agarose electrophoresis gels (Figure 19). Both peaks show broad bands which 
moved faster than Hb A toward the cathode, meaning that both were crosslinked 
hemoglobins. However, Sephadex A-50 did not successfully purify these reaction 
mixtures. Each peak was still composed of a mixture of crosslinked hemoglobins. 
All the four fractions from both oxyhemoglobin and deoxyhemoglobin reactions 
were subjected to SDS-PAGE gel electrophoresis (Fig. 20). The first peaks from both 
reactions (Fig. 18A and l 8B) were composed of both monomers (55 % ) and dimers 
(45%, Table 9). The SDS results of the second peaks from both reactions (Fig. 18A and 
18B) demonstrated the presence of monomer, dimer and a small amount of trimer. But 
the gel scans showed that the ratio of monomer, dimer and trimer for crosslinking 
reaction under different condition were similiar. They both had the same amount of 
monomer, but the second peak from the deoxyhemoglobin reaction contained a little 
more trimer and less dimer than the oxyhemoglobin reaction, 4.6 % vs. 2.0 % for the 
93 
Fig. 18A. Elution profile of the reaction products between oxyhemoglobin and 
DFDNB. The first pH linear gradient was 0.05 M Tris, pH 8.0 to pH 6.5. The second 
salt (NaCl) linear gradient was 0 to 0.5 M of 0.5 M Tris, pH 6.5. The flow rate was 
15 ml/h. The effluent was monitored by absorbance at 280 nm. The trace shown was 
not started until the hemoglobin was near the bottom of the column. 
Fig. 18B. Elution profile of the reaction products between deoxyhemoglobin and 
DFDNB. The conditions for chromatography were the same as for Fig.18A. 
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Fi~. 19. Alkaline agarose gel analysis of the Sephadex A-50 column fractions of 
DFDNB crosslinked hemoglobin (Fig. 18A and 18B). HbA (lane 1,4 and 7), Peak I of 
Fig. 18A (lane 2), peak II of Fig. 18A (lane 3), peak I of Fig. 18B (lane 5), peak II of 
Fig. 18B (lane 6). 
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Fig. 20. SDS-PAGE analysis of the Sephadex A-50 column fractions of DFDNB 
crosslinked hemoglobin. Lane I is Hb A, lane 2 and 7 are standard protein markers, 
lane 3 is peak I of Fig. 18A, lane 4 is peak II of Fig. 18A, lane 5 is peak I of Fig. 18B, 
and lane 6 is peak II of Fig. 18B. The standard protein markers are a-Lactalbumin (Mr 
14,400), Trypsin inhibitor (Mr 20,100), Carbonic Anhydrase (Mr 30,000), Ovalbumin 
(43,000), Albumin (Mr 67,000) and Phosphorylase b (Mr 94,000). 
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Table 9 
Percentage of Hemoglobin Subunits Crosslinked by DFDNB under Oxy and 
Deoxy Conditions 
Hb A state 
DFDNB-XLHbA 
(oxy) 
DFDNB-XLHbA 
(deoxy) 
Peak* 
I 
II 
I 
II 
Monomer 
54.3% 
35.3% 
55.9% 
35.0% 
Dimer 
45.6% 
62.7% 
44.1% 
60.4% 
Trinu 
2.0% 
4.6% 
* the numbering refers to the peak obtained by sephadex A-50 anion exchange 
chromatography 
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trimer and 60.4% vs. 62.7% for dimer (Table 9). 
Thermal Stability of DFDNB Crosslinked Hemoglobin 
The crosslinking reagent DFDNB could react with both oxyhemoglobin and 
deoxyhemoglobin, but the products can not be separated totally by a Sephadex A-50 
column as judged by alkaline agarose and SDS gels. Figure 21 shows the first derivative 
spectra of the absorbance at 406 nm with respect to temperature for the DFDNB 
crosslinked hemoglobins under oxy and deoxy conditions. There were no significant 
differences on thermal stability between the crosslinked hemoglobin which were reacted 
with DFDNB under the two reaction conditions (Table 10). There were two denatured 
transitions Tm's for both peak I and peak II from the oxy and the deoxy reactions. The 
Tm's of the first and second denatured transitions are about 3.5 to 5.0 ·c and 18.8 to 20 
°C higher than native hemoglobin for both cases. These finding agree with the results 
of alkaline agarose electrophoresis that both peak I and peak 11 were heterogeneous. 
Although both peaks showed two transitions, the sizes of the transitions of these peaks 
were different. Both peaks I, had large denaturation transitions at Low temperature and 
small transitions at high temperature, while both second peaks had large transitions at 
high temperature and small transitions at low temperature (Fig. 2 L). These results 
suggested that the reactions may have happened both between two subunits and within 
one subunit. The low denaturation transition may be due to the intra-chain crosslinking 
whereas the high denatured transition by the inter-chain crosslinking. The first peaks 
from both reactions may compose more intra-chain crosslinked hemoglobin species and 
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Fig. 21A. First derivatives of the Soret absorbance for the reaction products of 
between oxyhemoglobin and DFDNB with respect to temperature. Hb A (-- ), peak 
I of Fig. 18A (--),and peak II of Fig. 18A (-------}. 
Fig. 21B. First derivatives of the Soret absorbance for the reaction products of 
deoxyhemoglobin with DFDNB with respect to temperature. Hb A ( --) , peak I of 
Fig. 18B (- -), and peak II of Fig. 18B (-- --). 
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Table 10 
Tm and t:. T Values of Hemoglobin Modified by DFDNB 
sample Transition* ti. T 
HbA 40.8±0.6 
DFDNB-XLHbA I 45.8±0.4 5.0+0.4 
(oxy",Pl®) II 61.7±0.5 20.9±0.5 
DFDNB-XLHbA I 46.0±0.5 5.2±0.5 
(oxy" ,P2®) II 60.8±0.6 20.0±0.6 
DFDNB-XLHbA I 44.4±0.4 3.6±0.4 
(deoxy",Pl®) II 62.8+0.5 22.0±0.5 
DFDNB-XLHbA I 44.3±0.5 3.5+0.5 
(deoxy",P2®) II 61.6±0.5 20.8±0.5 
* -- denaturation transition 
@ -- Peaks from the A-50 column 
# -- Condition of crosslinking reactions 
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the second peaks had more inter-chain crosslinked hemoglobin species. The thermal 
denaturation temperatures for the second peaks in both cases are higher than those of 
other crosslinked hemoglobins made with longer crosslinking reagents. 
Oxygen Binding Properties of DFDNB Crosslinked Hemoglobin 
The oxygen affinities of DFDNB crosslinked hemoglobin were measured on a 
Hemox analyzer. Figures 22 and 23 show the oxygen binding curves and the Hill plots. 
Table 11 lists the P 50 and nmax values of these crosslinked species. All the crosslinked 
hemoglobin species had very high oxygen affinity (P50 =5.7-6.0 mmHg), and almost no 
cooperativity (n = 1). The P 50 values of the products of the crosslinking reaction which 
were carried under oxy conditions showed no affect with or without the presence of 
IHP, but the P 50 values of the crosslinked hemoglobins under deoxy conditions were 
affected by the presence of IHP. Without IHP the P50 value was about 5.7. The P50 value 
changed from 5. 7 to 11.1 with the presence of IHP. There was almost no differences 
between the two peaks. 
V. Double Crosslinking a99XLHbA and B82XLHbA with DFDNB 
The fumarate-crosslinked hemoglobins, a99XLHbA and J382XLHbA, were 
further reacted with DFDNB to produce double crosslinked hemoglobins. Table 12 lists 
the SDS gel scan results of single crosslinked hemoglobins, 0t99XLHbA and 
'382XLHbA, and the double crosslinked hemoglobins, a-DFDNB-XLHb A and '3-
DFDNB-XLHb A. The DFDNB reaction with a99XLHb A and {382XLHbA yielded 
predominantly dimers and monomers, and only very small fractions of trimers and 
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Fig. 22A. Oxygen equilibrium curves for DFDNB-modified oxyhemoglobin. The 
experiments were carried out in 0.05 M phosphate buffer with 135 mM KCI, pH 7.4, 
at 37 °C. From left to right the curves are peak I of Fig. 18A, peak II of Fig. 18A and 
HbA. 
Fig. 22B. Hill plots for the reaction products of oxyhemoglobin with DFDNB. ( 0) 
HbA, (D) peak I of Fig. 18B, and (+)peak II of Fig. 18B. 
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Fig. 23A. Oxygen equilibrium curves of products of DFDNB with deoxyhemoglobin. 
From left to right the curves are peak I of Fig. 18A, peak II of Fig. 18A and Hb A. 
Fig. 23B. Hill plots for the reaction products of deoxyhemoglobin with DFDNB. ( <>) 
HbA, (D) peak I of Flg. 18B, and (+)peak II of Fig. 18B. 
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Table 11 
Effects of Crosslinking on the Oxygen Affinity of D FD NB 
Crosslinked Hemoglobin at pH 7.4 and 37 "C. 
Samples P50. 
DFDNB-XLHbA 5.9±0.2 1.1±0.1 
(Oxy, peak I®) 
DFDNB-XLHbA 6.0±0.2 1.1 ±0.1 
(Oxy, peak II) 
DFDNB-XLHbA 5.7±0.2 1.1 ±0.1 
(deoxy, peak I) 
DFDNB-XLHbA 5.9±0.2 1.1±0.1 
(deoxy, peak II) 
* No IHP present 
# IHP present, IHP:Hb1',1r = 1: 1 
p # 50 
5.9±0.3 
5.9±0.2 
11.1±0.2 
11.0±0.2 
@ The peaks from DEAE-Sephadex A-50 column 
n' 
1.0±0.1 
1.0±0.2 
1.3±0.2 
1.2±0.2 
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Sample 
a99XLHbA 
j382XLHbA 
a-DFDNB 
XLHbA 
13-DFDNB 
XLHbA 
Table 12 
Relative Percentages of SDS-PAGE Bands of Hemoglobin 
Double Crosslinked by DBSF and DFDNB 
Monomer 
52.6 
54.5 
27.6 
29.88 
Dimer 
47.4 
45.5 
68.3 
67.52 
Trimer 
2.2 
1.4 
110 
Tetramer 
1.9 
1.2 
111 
tetramers. The corresponding percent of each species were about 16-22 % monomers, 
69-72 % dimers, 3-5 % trimers and 4-8 % tetramers. Compared with the SDS results, 
of single crosslinked hemoglobinsthe double crosslinking reactions caused an 
approximate 20 % increase in the dimer species. This demonstrated that DFDNB could 
crosslink hemoglobin between the two a chains or between the two (3 chains. There was 
very little crosslinking reactions between the a and the f3 chains because there was only 
a very small amount of trimer present. 
The results of the thermal denaturation experiments of these double crosslinked 
hemoglobins are summarized in Table 13. In both cases there were two transitions, one 
at 55 °C and another at 63 °C. As we know the denaturation temperatures of a99XLHbA 
and {382XLHbA are about 57 °C. Therefore, the first transition may be the average 
denaturation temperatures of the uncrosslinked a99XLHbA or J382XLHBA and the 
DFDNB intra-chain crosslinked hemoglobin species. The second transition temperature, 
63 °C, was very close to the second denaturation transition temperature of DFDNB 
modified hemoglobins. 
VI. Single Crosslinking Hemoglobin with Bis(3,5-Dibromosalicy]) Sebacate 
Crosslinking and Purification of Crosslinked Hemoglobins 
The crosslinking reaction of hemoglobin with bis(3,5-dibromosalicyl) sebacate 
was carried out in 0.01 M MOPS, pH 7.0, 37 °C for 2 h. Anion exchange 
chromatography of the reaction products of Hb A treated with DBSS, shown in Figure 
Table 13 
Thermal Denaturation Temperatures of DBSF and DFDNB 
Double Crosslinked Hemoglobin at 406 nm 
HbA Tm (°C) 
HbA 41.0 ± 0.6 0 
a99XLHbA 56.4 ± 0.8 15.4 
~82XLHbA 56.6 ± 0.5 15.6 
a-DFDNB-XLHbA* 55.0 ± 0.7 14.0 
63.0 ± 0.6 22.0 
~-DFDNB-XLHbA* 55.2 ± 0.5 14.2 
63.1 ± 0.5 22.1 
*Samples were crude reaction mixtures without purification. 
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24, reveal the presence of three peaks. The second peak from the Sephadex A-50 
column was isolated by rechromatography on an anion-exchange FPLC column(Fig. 
25A). This purified component was designated DBSS-HbA. The third peak was smaller 
than peak II. It was also rechromatographied by anion-exchange FPLC, but the mixture 
could not be separated totally (Fig 25B). There were two very close peaks. 
Results of Electrophoresis 
Figure 26 shows the results of alkaline agarose gel electrophoresis of the 
compounds purified by Sephadex A-50 chromatography. Peak I from the A-50 column 
(Figure 24) moved as fast as the native hemoglobin which indicated it was uncrosslinked 
hemoglobin. Peak II from the A-50 column (Figure 24) and the major peak from FPLC 
(Figure 25A) moved faster than peak I (uncrosslinked hemoglobin) and had a sharp 
band. Peak III had very broad bands that moved faster than those of peak II. This 
indicated that peak III is heterogeneous. 
The alkaline agarose gel electrophoresis was also run under the same conditions 
to compare the mobility of DBSS-XLHbA to those of a99XLHbA and J382XLHBA (Fig. 
27). The net charge of DBSS-XLHbA was the same as those of the other two single 
inter-chain crosslinked hemoglobins. 
The purified crosslinked hemoglobin species were subjected to sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis in a 12.5 % gel (Fig. 28). Peak I is the 
unreacted hemoglobin which shows only a monomer band. In addition to a band 
remaining in the position of the native globin monomer (Mr 16,000), a band appeared 
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Fig. 24. Chromatographic purification of DBSS-modified hemoglobin on a DEAE-
Sephadex A-50 column. Buffer A: 0.05 M Tris, 1 mM NaCN, pH 8.5. Buffer B: 0.05 
M Tris, 1 mM NaCN, pH 7.2. The flow rate was 15 ml/h. The trace shown was not 
started until the hemoglobin was near the bottom of the column. 
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Fig. 25A. Rechromatography of the major reaction product of DBSS-modified 
hemoglobin (Fig. 25, peak II) on a Mono Q column by the FPLC system. Buffer A: 
0.05 M Tris, 1 mM NaCN, pH 8.0. Buffer B: 0.05 M Tris, 1 mM NaCN, 0.2 M NaCl, 
pH 8.0. The flow rate was 0.5 ml/min. The elution was monitored by absorbance 280 
nm. 
Fig. 25B. Rechromatography of the minor reaction product of DBSS-modified 
hemoglobin (Fig. 24, peak 111) on a Mono Q column. 
A. 0.45 
0.4 
0.35 
0.3 
e 0.25 
c 
0 
.. 
!:!. 
.. 0.2 .a 
< 
0.15 
0.1 
0.05 
0 
B. 0.9 
0.8 
0.7 
0.6 
e 0.5 c 
0 
.. 
!:!. 
.. 0.4 .a 
< 
0.3 
0.2 
0.1 
0 
0 
0 10 20 
10 20 
30 
30 
40 
Time(min) 
40 
Time(min) 
117 
50 60 70 80 
50 BO 70 80 
118 
Fig. 26. Alkaline agarose gel results of DBSS-modified hemoglobin. lane 1 is HbA, 
lane 2 is DBSS-XLHbA (peak II of Fig. 24), lane 3 is DBSS-XLHbA after FPLC 
purification (Fig. 25 (A)), lane 4 is peak III of Fig. 24, lane 5 is the peak III which was 
rechromatographied on the FPLC system (Fig. 25 (B)), and lane 6 is uncrosslinked 
hemoglobin (peak I of Fig. 24). 
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Fig. 27 Comparison of alkaline agarose gel results of DBSS-XLHbA with those of 
(J82XLHbA and a99XLHbA. Lane 1 is HbA, lane 2 is DBSS-XLHbA, lane 3 is 
a99XLHbA, and lane 4 is (J82XLHbA. 
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in the Peak II, our desired product DBSS-XLHBA, which migrated in the position of 
a dimer (Mr 32,000), indicating the occurrence of a covalent intersubunit crosslink. The 
percentage of these two bands are 50-55% for monomer and 45-50% for dimer. The 
peak III had 50-55% of dimer. The summary of the SDS results are shown in Table 14. 
Since peak III is heterogeneous and probably composed of a mixture we decide to do 
only further analyze of the thermal stability, the oxygen affinity and the autoxidation 
rate of peak II, DBSS-XLHbA. 
Thermal Stability of Single Crosslinked Hemoglobin with DBSS 
The thermal stability of hemoglobin which was crosslinked by DBSS was 
determined and compared with that of uncrosslinked Hb A. Figure 29 shows the results 
of the thermal denaturation experiments of native Hb A and of DBSS-XLHbA. The 
change in Tm's of crosslinked Hb A relative to uncrosslinked HbA is summarized in 
Table 15. The Tm value of DBSS-XLHbA is 53.7 °C compared to 41.2°C for Hb A. The 
Tm's of DBSS-XLHbA and uncrosslinked Hb A were determined from the Soret band 
at 406 nm. The transition temperature of DBSS-XLHbA was lower than those of 
a99XLHbA and {182XLHbA, 53. 7 °C vs. 57 °C. This difference may related to the 
length of the crosslinking reagents. 
Oxygen Binding Results of DBSS Crosslinked Hb A 
One of the unique functional properties of DBSS-XLHbA is its low oxygen 
affinity. Without IHP present, its P50 value is 18.5 mmHg, which is lower than the P50 
of a99XLHbA,14.9 mmHg(Fig. 30). In addition, it remains cooperative with n_,.=2.2 
123 
Fig. 28. SDS polyacrylamide gel electrophoresis data of DBSS-modified hemoglobin. 
Lane 1 is peak I of Fig. 24, lane 3 and 4 are from the peak II of Fig. 24, lane 5 and 
6 are peak III of Fig. 24, and lane 2 and 7 are the standard marker proteins. The 
standard marker proteins are: bovine serum albumin (Mr 66K), egg albumin (Mr 45), 
glyceraldehyde-3-phosphate dehydrogenase (Mr 36K), carbonic anhydrase (Mr 29K), 
trypsinogen (Mr 24K), trypsin inhibitor (Mr 20.1) and a-lactalbumin (Mr 14.2). 
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Table 14 
Relative Percentages of SDS-PAGE Gel Electrophoresis Bands of 
Hemoglobin Modified with DBSS 
Samples 
DBSS-XLHbA (Pl) 
DBSS-XLHbA (P2) 
DBSS-XLHbA (P3) 
Monomer 
100% 
50-54% 
45-50% 
Pl the first peak from the A-50 column 
Dimer 
46-50% 
50-55% 
125 
P2 The second peak from the A-50 column which was further purified by FPLC 
P3 the third peak from A-50 column and further purified by FPLC 
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Fig. 29. Effect of DBSS-modification on the thermal stability of hemoglobin. The 
denaturation experiments were carried out in 0.01 M MOPS, pH 7.0. HbA ( ), 
DBSS-XLHbA (_ _ _). 
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Table 15 
Tm and c,. Tm Value of Bis(3,5-Dibromosalicyl) Sebacate 
Crosslinked Hemoglobin at 406 nm 
Tm (°C) 
41.2 ± 0.80 
53.7 ± 0.96 
AT (°C) 
0 
12.5 
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(Fig. 31). The P50 and nmax values of DBSS-XLHb A were not affected by the presence 
of IHP (Table 16). These results indicated that the BPG binding site was blocked by 
DBSS. The very low oxygen affinity of DBSS-XLHbA indicated that although the 
crosslinking reaction was carried out under oxyhemoglobin condition, DBSS properly 
selected the deoxyhemoglobin form for reaction and shifted the DBSS-XLHBA structure 
toward the deoxy form. 
Autoxidation Results of DBSS-XLHbA 
The autoxidation experiment of DBSS-XLHbA was carried out in 0.05 M 
MOPS, pH 7.4, at 37 °C. Figure 32A shows the visible spectral changes of DBSS-
XLHbA at 500 nm and 700 nm for a total of 17 h. Each spectrum was recorded every 
2 h. The detailed_time course of oxyDBSS-XLHbA, metDBSS-XLHbA and hemichrome 
formation is illustrated in Figure 32B. The major oxidation product was metDBSS-
XLHbA (characteristic peak at 630 nm) after 17 h. The amounts of hemichrome 
increased a little, about 5 % after 17 h. The autoxidation rate of DBSS-XLHbA was 
calculated from Figure 33. The autoxidation rate of DBSS-XLHbA was 5.38x10-2 h-1 
which is very close to the rate of a99XLHbA, 5.61 x 10-1 h-2 and faster than that of 
uncrosslinked hemoglobin, 4.06 x 10-2 h-1 and iS82XLHbA, 4.57 x 10-2 h-1 (Table 17). 
Purification of a and iS Globin Chains 
The globin chains of DBSS-XLHbA and Hb A were abstracted free of hemes 
and purified by carboxymethyl cellulose (CM-52) chromatography in 8 M urea, 
phosphate buffer. Figure 34A and 34B show the CM-52 chromatograms for elution of 
130 
Fig. 30A. Effect of DBSS-crosslinking on the oxygen equilibrium curves of 
hemoglobin in the absence of IHP. The oxygen binding curves were determined on a 
Hemox analyzer in 0.05 M phosphate buffer with 135 mM of KCL, pH 7.4, 37 °C. Hb 
A (1), DBSS-XLHBA (2). 
Fig. 30B. Oxygen binding curves of DBSS-XLHbA in the presence of IHP. IHP: Hb 
Au.1ra = 1:1. Hb A (1), DBSS-XLHbA (2). 
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Fig. 31A. Hill plots of DBSS-modified hemoglobin in the absence of IHP. Hb A (0), 
DBSS-XLHbA (+). 
Fig. 31B. Hill plots of DBSS-XLHbA (+)and HbA (0) in the presence of IHP. 
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Table 16 
Hill Coefficients (n) and P50 (mmHg) Values for DBSS-XLHbA 
HbA DBSS-XLHbA 
p50* 9.6 ± 0.3 18.5 ± 0.2 
* 2.4 ± 0.1 2.4 ± 0.2 n 
p50' 26.1 ± 0.4 18.6 ± 0.1 
n' 2.4 ± 0.2 2.3 ± 0.2 
*Without IHP present 
#With IHP present, DBSS-XLHbAtetra: IHP = 1:1. 
135 
Fig. 32A. Visible spectra of DBSS-XLHbA during an autoxidation experiment at 37 
°C. The spectra were recorded every 2 h. 
Fig. 32B. Time course of DBSS-XLHbA02 loss (D) and formation of metDBSS-
XLHbA ( +) and hemichrome ( <>). 
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globin chains from Hb A and DBSS-XLHbA, respectively. The elution resulted in two 
peaks of relatively equal amounts for both cases. Under these chromatographic 
conditions, the more negatively charged protein would be eluted first. Since the (3 the 
chain has a higher negative charge than the a chain for uncrosslinked hemoglobin, peak 
I would be (3 chain and peak II would be a chain (Fig. 34A). The elution time of the 
different globins in these chromatograms could not be compared since the columns were 
repacked and the buffers were remade. These changes may cause differences in the 
column bed volume and slight deviation in the salt gradient. Thus the protein in each 
peak was analyzed by SDS-PAGE gel (Fig. 35). The peak I from DBSS-XLHbA 
contains crosslinked globin dimer and those under peak II, uncrosslinked globin 
monomer. 
Amino Acid Analysis 
After the globin chains were hydrolyzed by 6 N HCl, the amino acids were 
derivatized by phenylisothiocyanate (PITC) to form phenylthiocarbamyl derivatives 
(PTC-amino acids) and the amounts of amino acids were identified and quantitated in 
reference to a mixture of seventeen amino acid calibration standards. The chromatogram 
of elution of the standard individual amino acids is shown in Figure 36, excluding 
tryptophan. Figures 37 and 38 show the elution profiles for the amino acids obtained 
from the hydrolyses of the isolated chains of Hb A and DBSS-XLHbA, respectively. The 
four elution profiles all show 15 amino acids in the hydrolysate. There was no Ile 
present because neither of the a nor (3 chains contained Ile. The Trp and Cys are 
138 
Fig. 33. Rates of autoxidation of HbA (0), DBSS-XLHbA (+). Ln [OxyHb A] was 
plotted as a function of time, at 37 °C. 
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Table 17 
Comparison of k,,PP (h-1) and Relative Rate Constant Values 
for Autoxidation of Hb A and Modified Hb A. 
Hb 
HbA 
{382XLHbA 
a99XLHbA 
DBSS-XLHbA 
4.06±0.37 
4.57±0.32 
5.61 ±0.28 
5.38±0.29 
~I 
1.00 
1.13 
1.38 
1.30 
r 
0.998 +0.011 
0.997 +0.015 
0.998 ±0.014 
0.998 ±0.012 
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Fig. 34A. Hb A globin chain separation on a CM-52 column. Buffer I: 5 mM 
N~HP04, 0.05 M 2-mercaptoethanol, 8 M urea, pH 6.7. Buffer II: 0.05 M N~HP04 , 
0.05 M 2-mercaptoethanol, 8 M urea, pH 6.7. The effluent was monitored by 
absorbance at 280 nm. 
Fig. 34B. DBSS-XLHbA globin chain separation on a CM-52 column. 
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Fig. 35. SOS-PAGE gel electrophoresis results of hemoglobin and DBSS-XLHbA 
globin chains. Lane 2 is the peak II of DBSS-XLHb (Fig. 34B); lane 3 is peak I of 
DBSS-XLHbA (Fig. 34B); lane 5 is a chain of HbA; lane 6 is J3 chain of HbA, lane 1 
and 4 are protein markers. The six protein markers are a-Lacta.lbumin (M, 14,400), 
soybean trypsin inhibitor (M, 20,000), carbonic anhdrase (M, 30,000), ovalbumin (M, 
43,000), bovine serum albumin (M, 67,000) and phosphorylyase b (Mr 94,000). 
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destroyed in the acid hydrolysis, and thus would not be expected to be present. Since 
glutamine and asparagine residues were hydrolysed to glutamate and aspartate and would 
be eluted under the known glutamate and aspartate peaks, the total amount of glutamine 
and glutamate, aspartate and asparagine together were reported as Glx and Asx, 
respectively. The number of amino acid residues of the 0t and {3 chains of Hb A found 
experimentally were compared to the theoretical numbers, and the amino acids residues 
of two purified globin chains of DBSS-XLHbA were all listed in Table 18. The number 
of amino acids residues obtained under the first peak of DBSS-XLHbA (Fig. 34B) 
matched with the number of amino acids residues from the experimental and theoretical 
values of the {3 chain. Based on the results of amino acid analysis and SDS-PAGE gel, 
this globin must be {3-{3 crosslinked. 
Peptide Mapping Results 
The tryptic digested {3-globin of native hemoglobin and DBSS-XLHbA were 
mapped by C-18 HPLC. Figure 39 shows the peptide maps of {3-globin chains of native 
hemoglobin and DBSS-XLHbA. The {3-globin chain of native hemoglobin should be 
digested into 15 different peptides. All 15 peptides are listed in Table 19. The peptide 
map of tryptic digested {3-globin chains of native hemoglobin (Fig. 39A) shows more 
than 15 peaks. We expected to see an identical pattern for native hemoglobin and DBSS-
XLHbA with only one or two peaks different, but the results could not tell us this 
specific difference. 
146 
Fig.36. Chromatogram showing the elution of standard amino acids by HPLC. 
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Fig. 37 A. Chromatogram showing the elution of amino acids from the ex globin of 
hemoglobin A (Peak II of Fig. 34A). 
Fig. 37B. Chromatogram showing the elution of amino acids from the f3 globin of 
hemoglobin A (Peak I of Fig. 34A). 
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Fig. 38A. Chromatogram showing the elution of amino acids of the a globins of 
DBSS-XLHbA under peak II of Figure 34B. 
Fig. 38B. Chromatogram showing the elution of amino acids of the (3 globins of 
DBSS-XLHbA under peak I of Figure 34B. 
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Table 18 
Comparison of the Number of Amino Acid Residues Found from Peaks I and II of 
Figure 34 to the Theoretical and Experimental Residues of the a and /J Chains 
AA • a (3" a+{3* a' {3' Peak I PeakII 
ASX D 12 13 12.5 11.8 13.1 13.3 12.1 
GLX E 
..2 ll 8.0 5.2 10.8 10.0 5.2 
SER s ll ..2 8.0 10.4 4.8 5.8 10.3 
GLY G J_ .Ll. 10.0 7.8 13.4 13.5 7.8 
HIS H 10 9 9.5 9.6 8.5 8.5 9.7 
ARG R 3 3 3.0 3.3 3.2 3.2 3.2 
THR T 9 7 8.0 8.8 6.6 6.6 8.7 
ALA A 21 u 18.0 21.2 15.0 14.9 21.0 
PRO p 7 7 7.0 7.8 7.7 7.9 7.8 
TYR y 3 3 3.0 3.2 3.1 3.2 3.2 
VAL v 13 18 15.5 12.8 17.6 17.4 12.7 
MET M 2 1 1.5 2.1 1.4 1.6 2.0 
CYS c 1 2 1.5 0.0 0.0 0.0 0.0 
LEU L 18 18 18.0 18.0 17.6 17.7 17.8 
PHE F 7 8 7.5 7.4 8.2 8.3 7.3 
LYS K 11 11 11.0 11.0 11.0 11.0 11.0 
TRP w 1 2 1.5 0.0 0.0 0.0 0.0 
Large differences in the number of amino acids between the a and /J chains are 
underlined. 
* the theoretical values # the experimental values 
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Fig. 39. Reverse-phase HPLC elution profiles of tryptic peptides of the {J chains from 
(A) HbA and (B) DBSS-XLHbA. 
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Table 19 
Amino Acid Sequences of the 15 Trypsin-Digested Peptides of Rb A f3 Globin 
VHLTPEEK 
SAVTALWGK 
VNVDEVGGEALGR 
LLVVYPWTQR 
FFESFGDLSTPDA VMGNPK 
VK 
AHGK 
K 
VLGAFSDGLAHLDNLK 
GTFATLSELHCDK 
LHVPENFR 
LLGNVLVCVLAHHFGK 
EFTPPVQAA YQK 
VVAGVANALAHK 
YH 
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CHAPTER IV 
DISCUSSION 
I. Purification of Hemoglobin from the Red Blood Cells 
The purification of hemoglobin from red blood cells was done by Sephadex 
diethylaminoethyl (DEAE) A-50 anion chromatography. The protejns were separated on 
this column as a function of net surface charge. Since the A-50 gel surface is positively 
charged, a protein with higher negative charge would be retained on the column longer 
than one which is less negatively charged. Normal adult hemolysate consist Hb A2, 
HbA and Hb A1c, etc. The major component is Hb A, which constitutes 92 % of total 
hemolysate. Hb A2 and Hb A1c are the other two components with percentages over 2 
% . Table 20 lists all the human hemoglobins components. Rb A, Hb ~ and Hb Ale have 
different net charges. The Hb A2 is a tetramer just like Hb A, but its tetrameicr form 
is a/)2• not cxj32• The primary sequence of the o chains has 10 amino acids different 
from the {3 chains of Hb A. The result of these differences is that the net charge of Hb 
A2 is more positive than HbA by +4 (97-99). On the other hand, Hb A1, is a derivative 
of Hb A in which the amino termini of the {3 chains have reacted with glucose forming 
Schiff base. Since the two positive charges were deleted by this reaction, the net charge 
of Hb Ale is 2 less than that of Hb A. Thus Hb A2 , Hb A and Hb A,, can be separated 
by an A-50 column. Because Hb A2 has more positive charges than Hb A and Hb Ale, 
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Hemoglobin 
A 
F 
Table 20 
Human Hemoglobin Components 
Structure 
not known 
not known 
% of normal 
adult hemolysate 
92 
2.5 
< 1 
< 2 
3 
< 1 
< l 
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it eluted from the A-50 column earlier than Hb A. Hb A has an intermediate charge 
between Hb A2 and Hb Ale; thus it eluted in the middle. Hb A1c has the highest negative 
charge among these three hemoglobins and eluted later than Hb A. The other unknown 
protein which eluted first from A-50 column must have a relatively high positive charge 
(Fig. 6). On the alkaline agarose gel, the sequence of these proteins moved toward the 
lower pH region was Hb Ale, Hb A, Hb Ai and the unknown protein, which matches 
well with the eluting order of proteins from anion exchange chromatography (Fig. 6). 
II. Double Crosslinking Hemoglobin With DBSF 
The crosslinking reaction of Hb A and a diaspirin reagent is shown in Figure 
40. The intermediate (I) may not persist since it is susceptible to hydrolysis, forming 
(11), or aminolysis by a second amino group to form a crosslinked product (Ill). As 
mentioned above, one of the diaspirin reagents, bis(3,5-dibromosalicyl) fumarate, could 
crosslink Hb A in the oxy state between Lys 82(31 and Lys 82/l2 , and between Lys 99a1 
and Lys 99a2 in the deoxy state. Thus the a{3 dimer dissociation was prevented by these 
crosslinks between identical subunits. Although the crosslinking of DBSF is highly 
selective and specific at these lysine residues, side reactions may have occurred under 
both reaction conditions. Both a and (3 crosslinked samples showed three bands on the 
clinical gel electrophoresis before purification with an A -50 c alum n. The bands 
correspond to one uncrosslinked hemoglobin and two crosslinked hemoglobins. Of the 
two crosslinked hemoglobin bands, one is {382XLHbA or a99XLBbA and the other is 
an unknown crosslinked hemoglobin which migrated slightly fas1er than ;382XLHbA or 
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Fig. 40. Crosslinking reaction of Hb A and a diaspirin reagent 
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a99XLHbA on alkaline agarose electrophoresis. The a99XLHbA and (382XLHbA have 
the same electrophoretic mobility. The unknown crosslinked hemoglobins from both 
reactions eluted after a99XLHbA and J382XLHbA from the A-50 column (Fig. 8A). 
Since the net charges of these unknown crosslinked hemoglobins were more negative 
than a99XLHbA and J382XLHbA, extra modification on other amino acids residues was 
indicated. The extra modification would delete the positive charge and make the protein 
more negatively charged. Therefore, they would elute after the o99XLHbA and 
J382XLHbA from the A-50 column. The side product of the J3 crosslinking reaction was 
very small. The major crosslinked product of J3 the crosslinking reaction is #382XLHbA. 
But the a crosslinking reaction had a higher yield of side product compared with the J3 
crosslinking reaction. The peak size of the side product was almost as large as the 
a99XLHbA on the Sephadex A-50 chromatogram (Fig. 8B). 
The doubly crosslinked hemoglobin, /3,a-XLHbA, was crosslinked by DBSF 
under two different oxygenation states. Since there were some side reactions during the 
deoxy crosslinking reaction, the side products were extra modified. The net charge of 
doubly crosslinked hemoglobin was similar to the extra modified side products, and the 
normal DEAE Sephadex A-50 column did not separate them well. The desired product 
needed rechromatography on the FPLC system (Fig. lOA). However, the yield of side 
products of the double crosslinking reaction was lower than in the a crosslinking 
reaction. This is not surprising since the BPG binding site was already blocked. There 
were only several very small peaks on the FPLC chromatogram (Fig. IOB). After /3,a-
XLHbA was purified on a DEAE-Sephadex A-50 column and rechromatographed on the 
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FPLC system, it gave a sharp band on alkaline agarose gels and moved faster than 
a99XLHbA or ~82XLHBA (Fig. 9). This agrees with the fact that the four positive 
charges were removed by the double crosslinking reactions. The net charge of 
~,aXLHbA would be lower than those of a99XLHbA and ~82XLHbA by -2. The SDS-
PAGE electrophoresis results showed two dimer bands and one monomer band. The total 
percentage of dimer was about 95 % (Table 3). It could be concluded that the second 
crosslinking reaction had modifying hemoglobin between the two a chains, and not on 
the two ~ chains or one a and one ~ chain. If the reagent was linked between two~ 
chains the percentage of dimer would still remain 50 % . It also did not happen between 
a and ~ chains, which would have caused a trimer band to appear on the SDS-PAGE 
gel. 
The a99 Lys is located in the central cavity of the hemoglobin tetramer near 
the middle of the hemoglobin molecule, more than 25 A from the entrance to the central 
cavity, while the ~82 Lys is located at the entrance of the central cavity between the two 
~ chains. In principle, the DBSF could enter the central cavity through the cleft between 
either a or~ chains to react with a99 Lys. However, Chatterjee et al. (39) found that 
the predominant reaction pathway is between the two a chains. They tested this by 
adding IHP to the reaction mixture to block the BPG binding site. The yield of 
a99XLHbA was markedly increased when the reaction was carried out in the presence 
of IHP. This result indicated that the major side reactions which occur are with the 
amino groups of the ~ chains that lie with in the 2,3-BPG binding site, which was 
proved both by Yang and Olsen in 1989 (48) and our present investigation. One of the 
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major side products of deoxyhemoglobin and DBSF was purified by Yang and Olsen 
(48). The amino acid analysis indicated that this hemoglobin was crosslinked between 
the two {3 chains. Since the oxygen affinity of this crosslinked hemoglobin was not 
affected by the presence of IHP which means that the BPG binding site was blocked by 
the crosslinking reagent (Table 4). 
For the double crosslinking reaction, after the {382 Lys were reacted with 
DBSF, the entrance between the two (3 chains to the central cavity was blocked by the 
crosslink. The second molecule of DBSF must get in from the other end of the channel, 
between the two ex chains. The chromatogram of doubly crosslinked hemoglobin (Fig. 
10) indicated {3,ex-XLHbA is the dominant crosslinked product. The BPG binding site 
was blocked by the first crosslink so that the second DBSF had to go through between 
the ex chains to react with the a99 Lys and the side product between the fJ chains was 
eliminated. The SDS gel result demonstrated that the second crosslink was between the 
two ex chains. Since DBSF has a very high specificity to crosslink deoxyhemoglobin ex 
chains between the two 99 Lys and the major side reactions between deoxyhemoglobin 
and DBSF occurred between two (3 chains. If there was another crosslinking site on the 
two ex chains, the reaction products would show at least a mi;(ture. Thus, the most 
possible crosslinking sites of the second crosslinking reaction is between the Lys99ex1 and 
the Lys99ex2• 
The structural analysis supports this hypothesis. The examination of the 
structure of the crosslinked hemoglobin, (382XLHbA, revealed that local perturbation 
occurred around the crosslink in the BPG binding cavity which caused the /3 F helix, the 
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{3 EF corner, His 143 {3 and the {3 amino termini to move slightly toward the center of 
the cavity. But the overall structure did not change (37-38,44). Thus the second DBSF 
molecule could still go through the region between the a chains and react with a99Lys. 
The thermal denaturation of hemoglobin could be obs.erved at several 
wavelengths corresponding to different chromophores in the protein. The most useful 
chromophores on the protein were the heme group and the aromatic amino acids. The 
wavelength we used in this dissertation was 406 nm. In all the experiments, 0.9 M of 
guanidine was added to keep the hemoglobin from precipitating during the denaturation. 
It was reported that the conditions required to denature horse ferrimyoglobin were 2-3 
M guanidine for 24 hour (101-102), which demonstrated that the globin fold should be 
intact in 0.9 M guanidine. The spectrum of methemoglobin remained the same in 0.9 
M guanidine after 24 hour at room temperature, indicating that guanidine alone at this 
concentration did not denature the hemoglobin. The increasing temperature is responsible 
for the transition to the denatured state. But the presence of guanidine may lower the 
transition temperature. 
Hemoglobin unfolding is a multi-step process. During the denaturation, 
methemoglobin dissociates to dimers and then to monomers, followed by unfolding of 
the chains to a partial denatured state, where the hemes may be lost~ and finally by to 
an irreversibly denatured state. Alternatively, the distal histidine could be coordinated 
to the iron to form a bis-imidazole complex. When hemoglobjn was covalently 
crosslinked between the two a or the two {3 chains, thermal denaturation would not 
break these bonds, leaving the crosslinked a or {3 chains intact. Jn the initial step of 
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tetramer dissociation, the two a{3 dimers would be held together by the crosslinker. This 
would produce a very high local concentration of dimers which favors tetramer 
formation by Le Chatelier's principle. The fact that the singly crosslinked hemoglobins, 
a99XLHbA and {382XLHbA, have a great increased thermal stability compared with the 
uncrosslinked hemoglobin supports this hypothesis. The second crosslink could further 
lock the tetramer with an additional increase in thermal stability. However, the increase 
in stability from the second crosslink would not be expected to be as dramatic as that 
from the first crosslink. The second crosslink only increased the Tm value by about 4°C, 
while the first crosslink increased the Tm value by about 15 °C, these observation also 
agree well with the proposal and supports the hypothesis that the dissociation from 
tetramer to a{3 dimer is the necessary step for hemoglobin denaturation. 
The functional consequences of crosslinking for a99XLHbA are distinct from 
those of {382XLHbA. a99XLHbA has a low oxygen affinity and a high autoxidation 
rate, while {382XLHbA has a high oxygen affinity and a slow au toxidation rate. It has 
been known for some time that the rate of autoxidation of hemoglobin is dependent on 
the quaternary structure of the molecule. The quaternary structures which are necessary 
for cooperative aspects of oxygen binding differ in their susceptibility to oxidation. 
Hemoglobin in the R state has a higher oxygen affinity and slower autoxidation rate than 
it does in the T state. The functional differences between these two singly crosslinked 
hemoglobins can be explained by stabilizing different structural states. The crosslinking 
in {382XLHbA holds it in the R state, while that in a99XLHbA holds it in the T state. 
The oxygen affinity of {3,aXLHbA is very similar to that of a99XLHbA, with 
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P50 value of 14.8 and 14.9, respectively (Table 4). The reason why ~,a-XLHbA has a 
low oxygen affinity may be due to the second crosslinking reaction being done in the 
T state, which means that {382XLHbA was forced to shift towards the T state. However, 
(382XLHbA may not be able to totally shift to the T state as uncrosslinked hemoglobin. 
A recent X-ray crystallographic study demonstrated that the local structure of deoxy 
(382XLHbA along the crosslink was different from the structure of deoxy Hb A. The two 
(3 Lys 82 of (382XLHbA were moved toward each other (44). This is easy to understand 
because the crosslinker. DBSF can only span 6.8 A which is shorter than the distance 
between the {382 Lys both in oxy and deoxy states. Thus, the ,B82XLHbA could not 
switch freely between the two states. The structure of (3,aXLHbA is likely to be 
intermediate between the T and R states. In the X-ray structure of deoxy~82XLHbA 
(44), the distal histidines of the /3 chains are in nearly the same positions as those in the 
oxy hemoglobin. This may also be the reason why the autoxidation rate of P,a-XLHbA 
is not as fast as a99XLHbA but close to those of (382XLHbA and HbA. 
III. Modification of Hemoglobin by DFDNB 
l,5-Difluoro-2,4-dinitrobenzene (DFDNB) is a short, neutral crosslinker. The 
distance between the two reactive sites is only 4.8 A. The mechanism of the reaction 
of DFDNB with amino groups is outlined in figure 41. As mentioned above, each 
hemoglobin molecule has a total of 48 primary amino groups, and most of them are on 
the surface of the hemoglobin tetramer. DFDNB would probably react with one of 
theseamino groups without special preference. When one reactive site of DFDNB has 
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Fig. 41. Mechanism of the reaction between DFDNB and amino groups. 
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reacted with the first amino group, the other reactive site would react with the nearest 
available amino group, since DFDNB is a short, reactive reagent. This may be the 
reason why the specificity of the crosslinking reaction is very difficult to control. With 
a high concentration of DFDNB, both inter- and intrasubunit crosslinking occurred. 
Since these modified hemoglobins may have the same net charge, the separation of this 
inter- and intrasubunit crosslinked mixtures on ion-exchange chromatography gave 
heterogeneous species, which showed broad bands on the alkaline agarose gel (Fig. 19). 
That DFDNB could crosslink hemoglobin between two subunits was proved by 
the SDS-PAGE results. DFDNB gave similar results under both oxy and deoxy reaction 
conditions. For both cases the crosslinked hemoglobins showed two peaks on the DEAE-
Sephadex A-50 column. The first peak was 44-46% of the dimer whereas the second 
peak was 60-63% of dimer on the SDS-PAGE gels. Although there was some trimer and 
tetramer bands, the yields of these species were very low. 
There were two distinct transition temperatures for DFDNB-crosslinked 
hemoglobin which could be due to the fact that the crosslinked hemoglobin was mixed 
with intra and inter subunits crosslinked hemoglobin (Fig. 21). The low transition, which 
was about 3.5 to 5 °C higher than normal hemoglobin, may be caused by the 
intrasubunit crosslinked hemoglobin. The high transition, which was 18.5-20 °C higher 
than that of uncrosslinked hemoglobin, may due to intersubunit crosslinked hemoglobin. 
White and Olsen (47) also found that two distinct transition temperatures occur for the 
{j82XLHbA with some uncrosslinked hemoglobin present, 40. 7 and 57.1 °C, whereas 
only one exists at the high transition temperature (57.1 °C) if /382XLHbA was very pure 
171 
(46). This indicated that the low transition temperature could be due to the minor 
amount of uncrosslinked hemoglobin. The high denaturation transition (.a. Tm= 20. 0-
22. 0 °C) is higher than that of any other modified hemoglobin which was crosslinked by 
a longer crosslinker, such as DBSF and DBSS; it was even higher than the denaturation 
temperature of the double crosslinked hemoglobin {j,aXLHbA (aTm=19.8°C). It is 
conceivable that the shorter crosslink would lock the hemoglobin tetramer more tightly 
and give a greater thermal stability. Although intra-chain crosslinking would not prevent 
dimer dissociation, the 3-5 °C increase in the denaturation temperature indicated that 
these is another factor involved in stabilizing the hemoglobin molecule. 
The DFDNB-crosslinked derivatives have high oxygen affinity and reduced Hill 
coefficients (Table 11). The loss of normal cooperativity (n= 1) of DFDNB-modified 
hemoglobin is anticipated because DFDNB is a very short crosslinker. The structure of 
DFDNB crosslinked hemoglobin is quite inflexible. This could be expected to restrict 
the tetramer movements during oxygenation. 
IV. Modification of Oxyhemoglobin by DBSS 
Analysis of Hb A treated with DBSS by anion-exchange chromatography 
revealed the presence of two products, peaks II and III, and some uncrosslinked 
hemoglobin, peak I (Fig. 24). Although both products were further purified by 
rechromatography on anion-exchange FPLC, but only peak II was purified successfully, 
peak III was not separated into pure components by FPLC. It still had very broad bands 
on the alkaline agarose gels, indicating heterogeneity (Fig. 26). 
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The thermal stability studies indicated that the Tm value of DBSS-XLHbA was 
about 12.5 °C higher than that of native Hb A. However, this increase in the Tm is less 
than observed with the shorter, stiffer fumarate crosslink, which was about 15. 6 °C for 
both a99XLHbA and {382XLHbA (Table 5). These results indicated that the shorter the 
crosslink, the higher the thermal stability of the crosslinked hemoglobin, which is also 
consistent with the DFDNB results. 
One unique functional property of DBSS-XLHbA is its low oxygen affinity. As 
we mentioned above, when oxyhemoglobin reacted with DBSF, the crosslinked 
hemoglobin {382XLHbA had a high oxygen affinity (Table 4). The DBSS also reacted 
with oxyhemoglobin, but the P50 was 18.5 mmHg which is even higher than the P50 value 
of a99XLHbA. This demonstrated that a shift in the conformational equilibrium must 
occur for this modified hemoglobin. The high Hill coefficient indicates that considerable 
cooperativity is retained by this modified hemoglobin. This suggests that the chemical 
modification does not freeze the molecule completely. The structure of DBSS-XLHbA 
is still quite flexible. Addition of IHP had no effect on the P 5() and the n values of 
DBSS-XLHbA, presumably due to blockage of the 2,3-BPG binding cleft by the DBSS 
molecule. 
The autoxidation of Hb A is dependent on the nature of the quaternary 
structures with deoxyhemoglobin being autoxidized faster than oxyhemoglobin (42). The 
fast rate of autoxidation of DBSS-XLHbA resulted from its T-state structure, as has been 
observed for other low affinity crosslinked hemoglobins (42). 
The results of SDS-PAGE and amino acid analysis indicated that DBSS is 
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crosslinked hemoglobin between the two (3 chains. The specificity of affinity labeling of 
hemoglobin in the BPG binding site is based on electrostatic interactions between the 
protein and the ligand as well as the reactivities of specific residues in the binding site. 
The structure of the BPG binding site, which contains four reactive primary amines, has 
been mapped by X-ray diffraction for both the oxy and deoxy quaternary structures. The 
distances between the reactive amino acid residues are listed in Table 21. The molecular 
modeling studies indicate that the distance between the two functional groups in the 
DBSS is approximately 12.8 A. Among the three pairs of amino acids, DBSS has a 
possibility to react between the two {382Lys or between one P82Lys and one /jl Val 
under both oxy- and deoxy- conditions. Although the distance between {382Lys and 
{31Val (15.2 A) is farther apart than the span of DBSS (12.8 A), the amino groups of 
{382Lys are on flexible side chains which can move into close proximity. The terminal 
Vall groups are not as free as Lys82 to move since they are attached directly to the 
protein's primary chain (103), so the reaction between DBSS and the two Vall groups 
is not possible. 
The peptide mapping experiments were done in order to find which two amino 
acid were reacted with the DBSS by comparing the chromatogram of digested peptides 
of the Jj chain of native hemoglobin and the (3 chain of DBSS-XLHbA. As mentioned 
above, after the globin chain was digested, the (3 chain of hemoglobin showed 16 
peptides (Table 19). If hemoglobin was crosslinked by DBSS between the two {382Lys, 
instead of 15 peptides there would be only 14 peptides. The two peptides containing 
{382Lys from each of the two (3 chains would be crosslinked by DBSS to form a longer 
AA residues 
{3182Lys-/3282Lys 
/31 l Val-/3282Lys 
/31 l Val-/321 Val 
Table 21 
Distances Between Reactive Amino Acid Residues 
in the Hemoglobin BPG Binding Site 
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d (A, oxy state) d (A, deoxy state) 
10.7 
15.5 
19.9 
9.3 
11.7 
18.4 
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peptide (VLGAFSDGLAHLDNLK-DBSS-KLNDLHALGDSFAGLV) and the original 
peptides with ~82Lys would disappear. In contract if DBSS crosslinked hemoglobin 
between ~82Lys and ~1 Val, there would only 13 peptides, the peptides with ~82Lys and 
~1 Val would disappear and one longer peptide containing the peptides of /j82Lys and 
al Val together would appear (VLDAFSDGLAHLDNLK-DBSS-VHLTPEEK). If the 
crosslinked peptides and their amino acid compositions could be identified, we could 
verify which two crosslinked positions was true. Unfortunately, the peptide 
chromatogram was more complex than we expected, and identification of the crosslinked 
peptide was difficult. The trypsin digest method was unable to solve this problem. We 
believe there are two ways to solve this problem, one is to label the DBSS, and other 
way is to analyze the amino acid sequence of each digested peptide. Unfortunately, the 
necessary equipment is unavailable. Recently Razynska et al. ( 100) found that when 
DBSS reacted with deoxyhemoglobin at a high molar ratio, deoxyhemoglobin was 
crosslinked between the two {382Lys by using peptide mapping and amino acid sequence 
analysis ( 100). 
Another alternative, but indirect way to identtify the crosslinked peptide is to 
calculate the minimum energy of DBSS bound to hemoglobin by molecular modeling 
which may provide an explanation of why (1) DBSS reacts with deoxyhemoglobin 
instead of oxyhemoglobin and (2) the reaction that crosslinks between the two {382Lys 
residue is possible, while the reaction between {382Lys and jjl Val is not. Since two 
possible crosslinking sites exist for DBSS between two ~82Lys or between /j82Lys and 
~1 Val, we tried two starting positions for energy minimization calculations. The first 
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had the DBSS between the two ,B82Lys. The minimum energy of DESS bound to both 
oxy- and deoxyhemoglobin was calculated using the Biosym Insight II/Discover package 
programs. The second starting position was between ,B82Lys and {31 Val. Similar 
calculations were done for DBSS bound to both oxy- and deoxyhemoglobin. The 
minimum energies for both positions are listed in Table 22. For both positions, the 
minimum energy for DBSS bound to deoxyhemoglobin was lower than that for DBSS 
bound to oxyhemoglobin in the agreement with our oxygen binding experiment results. 
Figures 42 and 43 show the final positions of DBSS bound to either oxy- or 
deoxyhemoglobin when DBSS was placed between the two {382Lys or between ,B82Lys 
and {31 Val. When DBSS was placed between the two {382Lys, the final position of 
DBSS remained between the two ,B82Lys; the position did not change markedly 
compared with the starting position under deoxy conditions (Figure 44). However, when 
DBSS was positioned between ,Bl Val and {382Lys as the starting position, the final 
position had a tremendous change (Fig. 45). It is clear that energy minimization moved 
the reagent away from the /) 1 Val to a position close to /)82Ly s. However, the final 
positions of DBSS for the two different starting positions in deoxyhemoglobin were 
different (Fig. 46). 
The distances between the reactive sites of DBSS to the P82Lys and {31 Val are 
listed in Table 23. Figures 47 and 48 show the detailed final structure of DBSS and of 
the four possible reactive amino acids, two ,Bl Val and two jl82Lys, in both oxy and 
deoxyhemoglobin. The distance between the /)82Lys residue to DBSS was shorter than 
that of {31Val. The distance between DBSS to the {382Lys of oxyhemoglobin was a little 
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Table 22 
Minimum Energies for DBSS Bound to Hemoglobin 
Energy {382Lys-{382Lys /31 Val-~82Lys 
OxyHb A deoxyHb A oxyHb A deoxyHb A 
Total -85.8 -187.1 50.6 -181.3 
Bond 22.7 23.4 31.9 23.5 
Theta 8.2 10.6 13.8 14.5 
Phi 26.1 10.8 26.2 14.1 
Out of plane 24.4 31.2 24.4 30.8 
Nonbond 42.52 51.3 160.9 47.7 
Repulsion 212.5 201.3 399.1 196.1 
Dispersion -169.9 -150.0 -238.3 -148.4 
Coulomb -209. 7 -314.2 -206.6 -311.8 
178 
Fig. 42A. Final structure of DBSS in deoxyhemoglobin when DESS was placed 
between the two ~82Lys. 
Fig. 42B. Final structure of DBSS in oxyhemoglobin when DBSS was placed between 
the two ~82Lys. 
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Fig. 43A. Final structure of DBSS in deoxyhemoglobin when it was placed between 
/HVal and {382Lys. 
Fig. 43B. Final structure of DBSS in oxyhemoglobin when it was placed between 
{31 Val and /382Lys. 
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Fig. 44. Initial (light) and final (dark) structures of DBSS in deoxyhemoglobin when 
it was initially placed between the two /382Lys. 
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Fig. 45. Initial (light) and final (dark) structures of DBSS in deoxyhemoglobin when 
it was initially placed in between {Jl Val and {J82Lys. 
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Fig. 46. Comparison of the final structures of DBSS in deoxyhemoglobin when it was 
placed in two different starting positions. DBSS was intially placed between {j82Lys and 
{j82Lys (light), and between {11 Val and {182Lys (dark). 
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Table 23 
Distances of {382Lys and {31Val to DBSS 
AA DBSS {382Lys-{382Lys Pl V al-{382Lys 
OxyHb A deoxy Hb A oxyHb A deoxyHb 
{3182Lys A 3.84 6.28 12.94 8.74 
{3282Lys A 10.26 5.95 2.92 3.68 
{3182Lys B 9.66 10.64 5.77 5.89 
{3282Lys B 4.02 3.74 5.67 10.81 
{31lVal A 7.06 13.94 17.77 12.28 
{321 Val A 15.43 6.35 3.35 7.69 
/j)Val B 14.82 9.08 10.54 5.89 
/j2 lVal B 7.48 11.57 10.93 15.40 
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Fig. 47 A. Structure of DBSS and of the four possible reactive amino acids in 
oxyhemoglobin when it was initially placed in between the two {J82Lys. 
Fig. 47B. Structure of DBSS and of the four possible reactive amino acids in 
deoxyhemoglobin when it initially was placed between the two {j82Lys. 
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Fig. 48A. Stucture of DBSS and of the four possible reactive amino acids in 
oxyhemoglobin when it was initially placed between {J 1 Val and {J 82Lys. 
Fig. 48B. Structure of DSBB and of the four possible reactive amino acids in 
deoxyhemoglobin when it initially was placed between {Jl Val and J382Lys. 
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shorter than that in deoxyhemoglobin. This may be due to the volume of the BPG 
binding site of oxyhemoglobin being smaller than that of deoxyhemoglobin. Thus, the 
limited space places the DBSS closer to the amino acids. However, the minimum energy 
and the stereo pictures of DBSS in both oxy- and deoxyhemoglobin (Fig. 49) indicated 
that the deoxyhemoglobin site was more favorable for binding DBSS and thus a more 
likely site for the crosslinking reaction. 
Although X-ray crystallography studies of DBSS-XLHbA will be necessary to 
determine the detailed structural effects due to crosslinking, the decreased oxygen 
affinity, the retention of the cooperativity, and the minimum energy value support the 
hypothesis that the allosteric equilibrium of DBSS-XLHbA is shifted towards the T-state 
by introducing the crosslinker. The most favorable amino acids of deoxyhemoglobin to 
crosslink DBSS were the two ,882Lys. 
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Fig. 49A. Stereo structures of DBSS in both oxy- (dark) and deoxyhemoglobin (light) 
when it was initially placed between the two /j82Lys. 
Fig. 49B. Stereo structures of DBSS in both oxy- (light) and deoxyhemoglobin (dark) 
when it was initially placed between /jl Val and /j82Lys. 
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APPENDIX 
CO-CROSSINKING HEMOGLOBIN TO CATALASE BY SULFO-SANPAH 
I. Introduction 
The autoxidation of hemoglobin A can be partially inhibited by either 
antioxidants (71-75) or particular enzymes (71, 7 4-77, 101-106). Catalase and superoxide 
dismutase are the most often used enzymes. Catalase inhibits autoxidation more strongly 
than superoxide dismutase (78-79). Our research work has emphasized the use of 
catalase. 
The prevention of oxidative damage to hemoglobin A by catalase has been 
studied by many researchers (71, 74-77, 107-112). Catalase is a heme-containing enzyme 
present in erythrocytes as well as in kidney and liver (79). Catalase exists in a tetrameric 
form, and has a molecular weight of 240,000 daltons. Catalase catalyzes the reaction 
(79-80): 
2H20 2 -- > 2H20 + 0 2 
The autoxidation of hemoglobin A was investigated by Misra and Fridovich 
(101). They found it to be caused by the self generation of 0 2·• and H20 2 • Since catalase 
can break down H20 2 , it could eliminate this intermediate. Therefore, it could reduce 
the autoxidation of hemoglobin. If the catalase could be linked to hemoglobin instead of 
just added it to the hemoglobin solution, it could reduce the autoxidation of hemoglobin 
201 
202 
more efficiently. 
Heterobifunctional reagents have been largely used as crosslinkers in 
biochemistry to study the interaction of different molecular species with each other. The 
crosslinker is usually bound to one molecular species via an amide bond, leaving a 
second photoactivatable site to form a convalent linkage with the other molecular species 
(81-83). The most common photoactive group is that aryl azide of diazo compounds, 
which are reasonably stable in the dark and form highly reactive nitrenes upon 
photoactivation. The photoreagent which we used is sulfosuccinimidyl 6-(4 '-azido-2 '-
nitrophenylamino)hexanoate (sulfo-SANPAH). The distance between the reactive sites 
is 18.2 A. The reaction scheme of sulfo-SANPAH with catalase and hemoglobin is 
presented in Figure 50. 
II. Procedures 
The reaction of catalase with sulfo-SANP AH was carried out at room 
temperature in the dark. Catalase was dissolved in 0.01 M borate buffer, pH 8.2. The 
molar ratio of catalase tetramer to sulfo-SANPAH was varied from 1:20 to 1:50. The 
reaction time was varied from 2-24 hours. The products were separated from the reagent 
by gel filtration on a Sephadex G-25 column in semi-darkness. Following incubation 
of the purified product from the above dark reaction with 10 fold to SO fold excess of 
hemoglobin in the dark, activation was accomplished by two light sources. One was a 
Ultrablitz comet 220 photography flash. The distance between the reaction cell and the 
flash was 2-4 cm. The sample cell was shaken between two flashes. The number of 
203 
Fig. 50. Reaction of sulfo-SANPAH with catalase and hemoglobin. 
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of flashes varied from 30 to 80. The other light source was a mogul-base sunlamp. The 
reaction cell was put on an ice bath to keep the temperature low. The distance between 
the reaction cell and the sunlamp was 20 cm. The reaction was stopped after 10 minutes. 
The products were separated by gel filtration over a Sephacryl S-200 column, 0.1 M 
borate buff er at pH 8. 2. 
III. Results and Discussion 
The reaction of catalase with the photo-heterobifunctional reagent Sulfo-
SANPAH was carried out in dark for 2 h. The reaction product was separated from 
excess sulfo-SANPAH by using Sephadex G-25 chromatography (Fig. 51). The second 
fraction which showed a red color was the unreacted sulfo-SANP AH. The first fraction 
was subjected on alkaline agarose gel and had increased mobility toward the anode 
compared with catalase (Figure 52). This result indicated this fraction was the product 
of the dark reaction since after reaction the net charge of catalase should be more 
negative than catalase. 
The first fraction from the G-25 column was mixed with hemoglobin and 
photolyzed by using a suntanning lamp as well as flash photolysis, then the mixture was 
separated by S-200 chromatography (Figure 53). The separations for both the suntanning 
lamp and the flash photolysis were very similar. There were three peaks in both cases. 
However, the SDS-PAGE results indicated all three fractions were a mixtures of catalase 
and hemoglobin. There was no catalase-hemoglobin complex present. If the catalase and 
hemoglobin were crosslinked by Sulfo-SANPAH, a band at a molecular weight over 
206 
Fig. 51. Separation of excess sulfo-SANP AH from the reacton product by using a 
Sephadex G-25 column. 
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Fig. 52. Alkaline agarose gel analysis of the products of the dark reaction. Lanes 1 
and 2 are catalase; lane 3 and 4 are the first peak from the G-25 column (Figure 51). 
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77000 would be expected. But there were no high molecular bands on the SDS-PAGE 
gel. 
We believe that the major problem is that the radicals formed upon 
photoactivation undergo side reactions, which dramatically reduce the chances to get a 
successful covalent crosslink. Since we did the reaction in a buffered solution, there 
were many water molecules surrounding the reagent. Moreover the molecular size of 
catalase is quite large, and before the hemoglobin molecule reaches close enough to 
catalase, the radicals formed upon photoactivation may already have reacted with the 
surrounding water molecules. Thus the reaction yield was very, very low. This problem 
illustrates why affinity crosslinkers, such as DBSF and DBSS, had much greater yields 
of the desired products. 
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Fi&. 53. Separation of the hemoglobin-catalase complex on a superfine Sephacyl S-
200 column. 
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